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HIERARCHICAL LIKELIHOOD INFERENCE ON CLUSTERED
COMPETING RISKS DATA
Nicholas J. Christian, PhD
University of Pittsburgh, 2011
Frailties models, an extension of the proportional hazards model, are used to model clustered
survival data. In some situations there may be competing risks within a cluster. When this
happens the basic frailty model is no longer appropriate. Depending on the purpose of the
analysis, either the cause-specific hazard frailty model or the subhazard frailty model needs to
be used. In this work, hierarchical likelihood (h-likelihood) methods are extended to provide
a new method for fitting both types of competing risks frailty models. Methods for model
selection as well as testing for covariate and clustering effects are discussed. Simulations show
that in cases with little information, the h-likelihood method can perform better than the
penalized partial likelihood method for estimating the subhazard frailty model. Additional
simulations demonstrate that h-likelihood performs well when estimating the cause-specific
hazard frailty model assuming both a univariate and bivariate frailty distribution. A real
example from a breast cancer clinical trial is used to demonstrate using h-likelihood to fit
both types of competing risks frailty models.
Public health significance: When researchers have clustered survival data and the obser-
vations within those clusters can experience multiple types of events the popular proportional
hazards model is no longer appropriate and can lead to biased estimates. For the results of
a clinical study to be meaningful the estimated effects of treatments and other covariates
needs to be accurate. H-likelihood methods are an alternative to existing procedures and can
provide less bias and more accurate information which will ultimately lead to better patient
care.
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1.0 INTRODUCTION
The proportional hazards model (Cox, 1972) is used to describe the relationship between
a set of explanatory variables and a possibly right-censored time to event outcome. One
of this model’s assumptions is that the event times are independent. However, there are
situations when this assumption is not appropriate. For example, the event times of related
individuals like family members are not independent; siblings share common genetic traits
as well as a common environment during childhood. Another example is when individuals
may experience an event more than once. Repeated event times for an individual can be
influenced by the person’s occupation, lifestyle, medical history, etc. In both these examples,
the event times are correlated and the proportional hazards model is no longer appropriate.
Ignoring the correlation can affect the result of the analysis by leading to underestimated
covariate effects (Barker and Henderson, 2005, Ha et al., 2001, Henderson and Oman, 1999).
An extension of the proportional hazards model is the shared frailty model, first intro-
duced by Clayton (1978). The shared frailty model accounts for dependent event times by
including a latent random effect called a frailty for each cluster which acts multiplicatively
on the hazard function. The frailty term represents the unobserved covariates that explain
why the event times are correlated. Given the frailty term, the event times within clus-
ters are conditionally independent. Frailties are assumed to be independent and identically
distributed random variables; often a lognormal or gamma distribution is used. The term
frailty was first introduced by Vaupel et al. (1979) for modeling population heterogeneity
using a univariate frailty model.
In some situations competing risks maybe present within clusters; subjects within a
cluster may experience more than one type of event where the occurrence of one of these
events prevents observing the other events for this subject. Similarly, subjects who experience
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repeated events may experience multiple types of events where a separate terminal event
precludes the occurrence of any future events. Only the terminal event censors the other
event times and not vice versa, this is a semi-competing risks situation (Fine et al., 2001).
For instance in cancer studies, patients can experience multiple event types: local, regional,
or distance recurrence as well as a new second primary cancer or death, where only the
occurrence of the death prevents the other events from being observable.
The basic frailty model assumes that within clusters censoring times are independent of
event times. Under competing risks and semi-competing risks this assumption is no longer
reasonable. Factors that affect one event type may also influence the probability of other
event types. Therefore it is necessary to incorporate competing risks along with clustering
effects in order to obtain unbiased estimates.
Huang and Wolfe (2002) present a model that extends the basic frailty model to include
competing risks. The model is fitted using the EM algorithm (Dempster et al., 1977), along
with Markov chain Monte Carlo (MCMC) simulation. This is a computationally intensive
approach that requires MCMC to perform numerical integration in the E-steps. Another
drawback of this approach is that the standard errors are not readily available. Instead they
need to be computed using Louis’ formula (Louis, 1982). In this work, a more general model
is introduced for modeling clustered competing risks by assuming a multivariate distribution
for the frailty terms, referred to as the cause-specific hazard frailty model.
Recently, Liu and Huang (2008) proposed using Gaussian quadrature to fit the shared
frailty as well as the competing risks model proposed by Huang and Wolfe (2002). Their
approach is easy to implement and requires less computation time than the EM algorithm.
However the method is not a true non-parametric procedure, a piecewise constant hazard is
assumed for the baseline hazard.
Another approach for handling clustered competing risks data is given by Katsahian
et al. (2006) and Katsahian and Boudreau (2011) who introduces an estimation procedure
for modeling the subhazard function (Fine and Gray, 1999) with clustered data, referred to
as the subhazard frailty model. The method proposed by Katsahian and Boudreau (2011)
relies on the penalized partial likelihood and can lead to biased estimates when there is little
information.
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In this work, an alternative estimation procedure is proposed using hierarchical likelihood
(h-likelihood) (Ha et al., 2001, Ha and Lee, 2003, Lee and Nelder, 1996). Unlike a traditional
likelihood function, the h-likelihood incorporates fixed effects as well as random effects into an
extended likelihood. As a result, the method does not require numerically intensive methods
to perform numerical integration like the EM-algorithm. Instead parameters are estimated by
using the Newton-Raphson method to maximize the profile and adjusted profile h-likelihoods
assuming a non-parametric baseline hazard. The Newton-Raphson method, a technique
that is faster than using the EM algorithm, has a quadratic convergence rate whereas the
convergence rate of the EM algorithm is linear (Tanner, 1996). Moreover, standard errors
are a result of the estimation procedure; no additional calculations are needed. Thus, the
hierarchical likelihood provides an approach that is faster than the EM algorithm and more
general than using Gaussian quadrature.
This work is organized as follows. In Chapter 2 methods for dealing with nuisance
parameters in the likelihood function are reviewed and the fundamentals of survival analysis
and competing risks are discussed. Then Chapter 3 discusses general characteristics of frailty
models as well as describes the basic univariate and shared frailty models and extends these
models to the cause-specific hazard frailty model and the subhazard frailty model. Next,
Chapter 4 derives the h-likelihood estimators for the cause-specific hazard frailty model and
the subhazard frailty model. Methods for statistical inference and model selection are also
presented. Chapter 5 presents a simulation study that demonstrates the performance of the
hierarchical likelihood estimators for clustered data with competing risks. In Chapter 6,
the h-likelihood estimation procedure is applied to a breast cancer dataset from a phase III
clinical trial; the h-likelihood can be useful when the goal of a study is the effect of a treatment
on multiple outcomes when these outcomes are correlated and subject to competing risks.
Finally, Chapter 7 discusses the results and describes future areas of research.
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2.0 BACKGROUND
The following chapter reviews relevant material from likelihood theory and survival anal-
ysis and introduces notation that will be used throughout this work. Section 2.1 reviews
techniques for dealing with nuisance parameters in the likelihood function. Particularly, the
adjusted profile likelihood which plays a major role within the h-likelihood estimation pro-
cedure. Section 2.2 covers the basics of survival analysis and competing risks which are used
for building competing risks frailty models. For a complete discussion, see Pawitan (2001)
and Severini (2000) for likelihood methods and Kalbfeisch and Prentice (2002) and Klein
and Moeschberger (2003) for survival analysis.
2.1 ADJUSTED PROFILE LIKELIHOOD
Let f(x|θ) denote the joint density function of a random sample X = (X1, X2, . . . , Xn) of size
n. The probability of the observed data x = (x1, x2, . . . , xn) where θ is the true parameter
is given by the likelihood function,
L(θ|x) ≡ f(x|θ). (2.1)
An appropriate estimate of θ is the point where the observed data is most likely or the
value that maximizes the likelihood function. Under regularity conditions, the maximum
likelihood estimate (MLE), θˆ, is asymptotically normal with mean θ and variance I(θ),
where I(θ) = E
(
− ∂2
∂θ2
logL(θ|x)
)
is the Fisher information matrix. From this asymptotic
result Wald hypothesis tests and confidence intervals can be used for approximate inference
of θ, where I(θ) can be estimated by, I(θˆ) = − ∂2
∂θ2
logL(θ|x)
∣∣∣
θ=θˆ
.
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In this section and throughout this work f , is used to denote a general density function
where the arguments and context are used to determine the meaning of the function. More-
over, all likelihood functions are conditional on the observed data. To simplify the notation
the observed data x will often be suppressed, L(θ) = L(θ|x). The log-likelihood function is
denoted by l(θ) = logL(θ).
More complex models require more parameters. Often only a subset of the parameters
are of interest to the researcher while the remaining parameters are just used to complete the
model and can be thought of as nuisance parameters. To simplify estimation and inference
it would be worthwhile to eliminate the nuisance parameters and construct a likelihood
function only for the parameters of interest.
Let (θ, η) be all the model parameters where θ is the parameter of interest and η is a
nuisance parameter; both θ and η may be vectors. One option is to replace the nuisance
parameter η with its MLE for each fixed value of θ; the subsequent likelihood is called the
profile likelihood. More formally, given the joint likelihood L(θ, η) the profile likelihood of θ
is given by
Lp(θ) = max
η
L(θ, η) (2.2)
where the maximization occurs for a fixed value of θ. Given θ, the MLE of η is often
a function of θ. So another way to express the profile likelihood is Lp(θ) = L(θ, ηˆθ) or
Lp(θ) = L(θ, ηˆ(θ)), where ηˆθ and ηˆ(θ) are both used to denote the MLE of η for a fixed value
of θ.
The profile likelihood can be used like a standard likelihood function and does reasonably
well with estimation and inference if the number of nuisance parameters is small relative to
the sample size. However, the profile likelihood is not a proper likelihood function; it is
not based on the distribution of observable data. Therefore there is the potential for biased
estimates and underestimated standard errors.
An alternative approach to eliminating nuisance parameters is to use the marginal or
conditional likelihoods, which are proper likelihoods. The marginal likelihood is formed by
finding a statistic T such that the distribution of T only depends on θ; then the marginal
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likelihood is the density of T as a function of θ. Formally, suppose there exists a statistic T
such that the density function of the data X may be written as,
f(x; θ, η) = f(t; θ)f(x|t; θ, η). (2.3)
Then the marginal likelihood based on the marginal distribution of T is,
L(θ; t) ≡ f(t; θ). (2.4)
The conditional likelihood requires finding a statistic S such that the conditional distri-
bution of the data X given S = s only depends on θ. Then the conditional likelihood is the
conditional density function of X given S = s as a function of θ. That is, suppose there
exists a statistic S such that,
f(x; θ, η) = f(x|s; θ)f(s; θ, η) (2.5)
where S is sufficient for fixed θ. It follows that the conditional likelihood function based on
the conditional distribution of X given S = s is,
L(θ;x|s) ≡ f(x|s; θ). (2.6)
Two assumptions are made regarding S. First, S is not sufficient in the full model with
parameters (θ, η). If it was, by the factorization theorem f(x; θ, η) = f(s; θ, η)f(x) and there
would be no conditional density or corresponding conditional likelihood that only depends
on θ. The second assumption is that S does not depend on θ.
Both the marginal and conditional likelihoods eliminate the nuisance parameter η. More-
over, they are both proper likelihoods because they are constructed from a density function,
that is they are based on the probability of the observed data. Thus the marginal and
conditional likelihoods usually correct the bias and variance of the profile likelihood. One
disadvantage of using conditional or marginal likelihoods is that all of the available informa-
tion about θ may not be used since f(x|t; θ, η) in (2.3) and f(s; θ, η) from (2.5) are ignored.
These ignored terms may contain useful information about θ that is not considered. Another
disadvantage of these models is that it may not be clear how to find the appropriate statistics.
Even if statistics exist, the exact form of the densities can be difficult to derive. One solution
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is to approximate the marginal or conditional likelihood by modifying the ordinary profile
likelihood (Barndorff-Nielsen, 1983). Below is a heuristic derivation of the approximation
(Pawitan, 2001).
First recall that under regularity conditions the MLE of θ, denoted θˆ, is approximately
normally distributed with expected value θ and variance I(θˆ)−1. Then the approximate
density of θˆ is,
f(θˆ) ≈ |I(θˆ)/(2pi)|1/2 exp
(
−1
2
I(θˆ)(θˆ − θ)2
)
. (2.7)
Furthermore, there is also the quadratic approximation,
log
L(θ)
L(θˆ)
≈ −1
2
I(θˆ)(θˆ − θ)2 (2.8)
found by using a second-order Taylor’s series expansion of the likelihood about θˆ. Substi-
tuting (2.8) into (2.7) gives the likelihood based p-formula,
f(θˆ) ≈ |I(θˆ)/(2pi)|1/2L(θ)
L(θˆ)
. (2.9)
This approximation of the density function of θˆ turns out to be more accurate than relying
on the fact that θˆ is asymptotically normal (2.7). For the multiparameter case, let (θˆ, ηˆ)
denote the MLE of (θ, η) and let I(θˆ, ηˆ) be the corresponding observed information. Then
the approximate density of (θˆ, ηˆ) using the multivariate p-formula is,
f(θˆ, ηˆ) ≈ |I(θˆ, ηˆ)/(2pi)|1/2L(θ, η)
L(θˆ, ηˆ)
. (2.10)
From (2.10) the approximate density function of ηˆθ given θ is,
f(ηˆθ) ≈ |I(θ, ηˆθ)/(2pi)|1/2 L(θ, η)
L(θ, ηˆθ)
. (2.11)
where L(θ, ηˆθ) is the profile likelihood of θ. It follows from (2.11) that the marginal density
of ηˆ is approximated by using the usual change-of-variable formula,
f(ηˆ) = f(ηˆθ)
∣∣∣∣∂ηˆθ∂ηˆ
∣∣∣∣
≈ |I(θ, ηˆθ)/(2pi)|1/2 L(θ, η)
L(θ, ηˆθ)
∣∣∣∣∂ηˆθ∂ηˆ
∣∣∣∣ (2.12)
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Then the conditional density of θˆ given ηˆ is,
f(θˆ|ηˆ) = f(θˆ, ηˆ)
f(ηˆ)
≈ |I(θˆ, ηˆ)/(2pi)|
1/2
|I(θ, ηˆθ)/(2pi)|1/2
L(θ, ηˆθ)
L(θˆ, ηˆ)
∣∣∣∣ ∂ηˆ∂ηˆθ
∣∣∣∣ (2.13)
where the p-formula is used on both the numerator and denominator. After ignoring terms
in (2.13) that do not depend on the parameters, an approximation to the conditional log-
likelihood for θ given ηˆ, that is the log-likelihood of θ obtained from f(θˆ|ηˆ) is,
l(θ) = l(θ, ηˆθ)− 1
2
log |I(θ, ηˆθ)/(2pi)|+ log
∣∣∣∣ ∂ηˆ∂ηˆθ
∣∣∣∣ . (2.14)
Using the marginal density of θˆ, f(θˆ) = f(θˆ, ηˆ)/f(ηˆ|θˆ), a formula identical to (2.14) is found
for approximating the marginal likelihood for θ based on θˆ; the likelihood for θ determined
by the marginal density of θˆ. Equation (2.14) is referred to as the modified profile likelihood
of θ and can be used to approximate either the marginal or conditional likelihood function
of θ.
The constant 2pi remains in (2.14) so that the formula closely resembles the log of a
proper density function. The last term, the Jacobian |∂ηˆ/∂ηˆθ| ensures that the modified
profile likelihood is invariant with respect to transformations of the nuisance parameter. The
Jacobian term can be a very difficult quantity to evaluate. In some cases ηˆ does not depend
on θ implying that ηˆ = ηˆθ and |∂ηˆ/∂ηˆθ| = 1. Generally it is not possible to parameterize
the model such that ηˆ = ηˆθ. If θ is a scalar, then Cox and Reid (1987) showed that it is
possible to set the nuisance parameter η such that |∂ηˆ/∂ηˆθ| ≈ 1 by choosing η such that θ
and η are orthogonal. Recall that two parameters are orthogonal if the diagonal elements of
the expected information matrix are 0,
E
(
∂2
∂θ∂η
l(θ, η)
)
= 0. (2.15)
If θ and η are orthogonal parameters then the modified profile likelihood can be approx-
imated by the adjusted profile likelihood defined as,
lA(θ) = l(θ, ηˆθ)− 1
2
log |I(θ, ηˆθ)/(2pi)|. (2.16)
8
The adjusted profile likelihood (2.16) can also be computed using Bayesian methods.
Bayesians assume parameters follow a distribution, as a result unwanted parameters can be
eliminated by integrating them out.
For scalar parameters, take the quadratic approximation
log
L(θ)
L(θˆ)
≈ −1
2
I(θˆ)(θˆ − θ)2
and integrate both sides with respect to θ then,
∫
L(θ) dθ ≈ L(θˆ)
∫
exp
(
−1
2
I(θˆ)(θ − θˆ)2
)
dθ
= L(θˆ)|I(θˆ)/(2pi)|−1/2. (2.17)
this is Laplace’s integral approximation (Tanner, 1996). If l(θ) is well approximated by
a quadratic then the formula is very accurate. For a two-parameter model L(θ, η) the
approximate integrated likelihood for fixed θ is,
LI(θ) ≡
∫
L(θ, η) dη ≈ L(θ, ηˆθ)|I(θ, ηˆθ)/(2pi)|−1/2. (2.18)
It follows that the first-order Laplace approximation of the integrated log-likelihood is iden-
tical to the adjusted profile likelihood (2.16) when the parameters are orthogonal,
lI(θ) ≈ l(θ, ηˆθ)− 1
2
log |I(θ, ηˆθ)/(2pi)|. (2.19)
The adjusted profile likelihood is used extensively with hierarchical likelihood methods
(Lee and Nelder, 1996, Ha et al., 2001, Lee et al., 2006). In chapter 4 the adjusted profile
likelihood is used to approximate the restricted likelihood of the frailty parameter θ.
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2.2 COMPETING RISKS
With some studies the outcome of interest is the time until the occurrence of a possibly
censored event. More generally, a subject may experience one of m different event types.
Or there may be more than one event time for each subject, where the repeated occurrences
could either be the same event type or different types of events. In other words, subjects
may have multiple failures where each failure is from a different cause.
For example, in an oncology clinical trial studying a new treatment subjects can experi-
ence different types of events. They may have a recurrence of the original cancer, develop-
ment of a new cancer or they may die while in remission. There are also different types of
recurrence: local, regional or distance, depending on the site of the recurrence in relation to
the site of the initial cancer. Often only the first event is of interest since treatments after
the first event mask the effects of the treatment being studied. Thus the occurrence of one
of these events precludes us from observing the other event. The m different event types
are competing to be observed first and are referred to as competing risks (Prentice et al.,
1978, Kalbfeisch and Prentice, 2002). Other times, subjects are followed after the first event
and different types of recurrence or new primary cancers are observed until a terminating
event, such as death, precludes the occurrence of any future events. Only the terminal event
censors the other event times and not vice versa, this is an example of a semi-competing
risks situation (Fine et al., 2001).
Competing risks is also referred to as dependent or informative censoring where the
occurrence of the competing event censors the event of interest informatively. For example,
suppose subjects drop out of a study because of treatment side effects. The potential event
time of these subjects is related to experiencing these side effects. Since there is an association
between the event of interest and side effects, patients who dropped out of the study are
censored informatively; side effects should be considered a competing event. Subjects where
not censored randomly but where informatively censored for reasons related to treatment.
Many survival analysis methods assume that event and censoring times are independent.
With competing risks data this is assumption may not be reasonable. Factors that affect
one event type may also influence the probability of other competing events. Treatment may
10
lower the probability of recurrence for a subject, but may also increase their probability of
death due to treatment toxicity. So it may not be appropriate to treat time of death as an
independent censoring time when studying the time to recurrence.
On the other hand, there may be cases when competing risks are independent in which
case standard survival analysis methods that assume independent censoring can be used.
The problem is that there is not enough information in the data to test the assumption of
dependent or independent competing risks (Tsiatis, 1975). Observing only one event type
per subject does not provide sufficient information to estimate the association between event
types. There is always some degree of informative censoring in a study. Depending on the
nature of the study as well as the question being investigated competing risks may or may
not be worth accounting for. When necessary there are several ways to deal with dependent
competing risks (Moeschberger and Klein, 1995, Zheng and Klein, 1995). One approach is to
use quantities that do not make any assumptions about the dependence structure between
competing risks.
Using a statistical method that assumes independent competing risks when there is
actually an association can lead to bias results and faulty conclusions. A classic example
is the complement of the Kaplan-Meier estimator (Kaplan and Meier, 1958) of the survival
function, denoted 1 − KM . It is well known (Pepe and Mori, 1993, Gooley et al., 1999)
that this estimator overestimates the cumulative probability of an event of interest, in the
presence of competing risks. The reason for the overestimation is how 1−KM handles the
other event types. Subjects who experience a competing risk are treated just like subjects
who are independently censored for reasons like lost to follow-up. The overestimation is a
result of including subjects who failed from a competing risk and are not capable of a future
failure with subjects who have not had any events and are still at risk of failure. The 1−KM
estimator only considers the event of interest and does not account for events from other
causes. Thus, 1 −KM is interpreted as the probability of an event of interest by time t if
the competing events were removed or did not exist. A more appropriate estimator is the
cumulative incidence function discussed below.
There are several useful quantities for analyzing competing risks data: cause-specific
hazard functions, cumulative incidence functions and subhazard functions. These quantities
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are useful because they can be estimated and are identifiable from the observed data without
making any assumptions about the joint distribution of the event times.
Before discussing competing risks quantities the following survival notation is quickly
introduced; see Klein and Moeschberger (2003) for more details. Let T be a nonnegative
random variable from a homogeneous population that denotes the time to an event. Further
assume that T is continuous, similar quantities exists when T is discrete. This work assumes
that T is subject to right censoring, where all that is known is that a subject has yet to
experience an event by a given time.
The survival function is the probability of experiencing the event after time t or, in other
words, the probability of surviving until time t,
S(t) = P (T > t) =
∫ ∞
t
f(t) dt, (2.20)
where f(t) is the probability density function of T . The survival function is a monotone
non-increasing function equal to one at zero and approaches zero as time goes to infinity.
The survival function can also be calculated using the cumulative distribution function F (t)
of T , S(t) = 1− F (t). Thus, there is a connection between f(t) and S(t),
f(t) =
dF (t)
dt
=
d(1− S(t))
dt
= −dS(t)
dt
. (2.21)
The hazard function or hazard rate is the instantaneous event rate at time t given an
individual has reached time t without experiencing the event. The hazard function is defined
as,
λ(t) = lim
∆t→0
P (t ≤ T < t+ ∆t|T ≥ t)
∆t
. (2.22)
Unlike the survival function the only restriction on the hazard function is that it be non-
negative; hazard rates can be constant, increasing, decreasing, convex or concave. The
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hazard function can be expressed in terms of f(t) and S(t),
λ(t) = lim
∆t→0
P (t ≤ T < t+ ∆t|T ≥ t)
∆t
= lim
∆t→0
P (t ≤ T < t+ ∆t)
∆tP (T > t)
= lim
∆t→0
F (t+ ∆t)− F (t)
∆tP (T > t)
=
f(t)
S(t)
. (2.23)
Using (2.21) and (2.23) the hazard function can also be written as,
λ(t) = − d
dt
log(S(t)). (2.24)
The cumulative hazard function is,
Λ(t) =
∫ t
0
λ(u) du = − log(S(t)) (2.25)
where the last term comes from integrating both sides of (2.24). Finally, it follows from
(2.25) that,
S(t) = exp(−Λ(t)) = exp
(
−
∫ t
0
λ(u)
)
du. (2.26)
Now back to competing risks, let Tk, k = 1, 2, . . . ,m denote the event time for event type
k. Then the observed event time T in the presence of competing risks is the minimum of all
of the potential event times T = min(T1, T2, . . . , Tm). Define the event indicator δk = 1 if
the type k event occurs first, T = Tk, and 0 otherwise.
A useful quantity for modeling competing risks is the cause-specific hazard rate for event
k,
λk(t) = lim
∆t→0
P (t ≤ T < t+ ∆t, δk = 1|T ≥ t)
∆t
. (2.27)
The function λk(t) is the rate of experiencing a type k event in the next instance given
that the subject has yet to experience any of the competing events. If the event types are
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mutually exclusive and cannot occur simultaneously, then the overall hazard rate is the sum
of the cause-specific hazard rates,
λ(t) =
m∑
k=1
λk(t) (2.28)
and the overall survival rate is S(t) = exp(− ∫ t
0
∑m
k=1 λk(u) du). The cumulative hazard rate
for event k is Λk(t) = −
∫ t
0
λk(u) du.
The cumulative incidence function Fk(t) is the probability of the event of interest occur-
ring before time t where an individual is exposed to all event types,
Fk(t) = P (T ≤ t, δk = 1) =
∫ t
0
fk(u) du (2.29)
where fk(t) =
d
dt
Fk(t) is the subdensity function. Notice that the cumulative incidence
function is an improper distribution since,
lim
t→∞
Fk(t) = lim
t→∞
P (T ≤ t, δk = 1) = lim
t→∞
P (T ≤ t|δk = 1)P (δk = 1) = P (δk = 1).
Thus Fk(t) is also referred to as a subdistribution function.
Since F (t) =
∑m
k=1 Fk(t) ≤ 1, it follows that the probability of one event type will be
low if the probability of the other events is high because the sum of cumulative incidence
functions cannot exceed one. Therefore, estimators for all event types need to be considered
simultaneously in order to give an appropriate interpretation (Korn and Dorey, 1992, Pepe
and Mori, 1993).
It may seem worth considering 1 − Fk(t). However this quantity has a very awkward
interpretation, it is the probability that nothing happens until time t, but when something
does happen it needs to be event k. The cumulative incidence function Fk(t) gives a more
natural interpretation, the probability of event k by time t (in the presence of competing
risks).
The subhazard function is the hazard function of the subdistribution,
γk(t) = lim
∆t→0
P (t ≤ T < t+ ∆t, δk = 1|T ≥ t ∪ (T ≤ t ∩ δk = 0))
∆t
=
fk(t)
1− Fk(t)
= − d
dt
log(1− Fk(t)). (2.30)
14
It follows, that the cumulative incidence function is a function of the cause-specific hazard or
the subhazard. Following the steps used to get (2.23) it is easy to show that fk(t) = S(t)λk(t).
Then,
Fk(t) = 1− exp
(
−
∫ t
0
γk(u) du
)
=
∫ t
0
S(u)λk(u) du (2.31)
Differentiating both sides of (2.31) with respect to t and rearranging the terms gives the
following relation between the subhazard function and the cause-specific hazard function,
λk(t) =
(
1− Fk(t)
S(t)
)
γk(t). (2.32)
Lastly, let ti be the observed event time for the ith subject in a sample of size n and
let δik be the type k, k = 1, 2, . . . ,m event indicator for subject i when there are m event
types such that δik = 1 if a type k event occurs at time ti and δik = 0 otherwise. Then the
likelihood assuming independent censoring is,
L =
m∏
k=1
n∏
i=1
λk(ti)
δik exp (−Λ0k(ti)) . (2.33)
where Λ0k is the baseline cumulative hazard function.
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3.0 FRAILTY MODELS
In some studies, the observed event times may not be independent. For example, siblings
share common genetic traits as well as a common environment during childhood. These
shared characteristics tend to make the event times of family members correlated. However,
different families have different characteristics so event times between families may be in-
dependent. Another example is a multi-center clinical trial. A subject’s outcome may be
influenced by the type of care received at a particular institution. Therefore the event times
for subjects from the same center may be correlated while the event times between different
centers with different practices may be independent. Repeated outcomes recorded on the
same individual over time will also tend to be related. Individuals have unique lifestyles,
medical history and genetic traits that can make repeated event times for the same subject
dependent. In all of these examples there are clusters of similar observations. The event
times within these clusters tend to be correlated because members of a cluster share certain
characteristics. Event times between clusters are typically independent because different
clusters have different attributes.
When the event times are correlated, the proportional hazards model is no longer appro-
priate since this model assumes independent event times. Not recognizing the dependence
within the data and fitting the usual proportional hazards model can lead to underesti-
mating standard errors and covariate effects (Barker and Henderson, 2005, Ha et al., 2001,
Henderson and Oman, 1999).
An extension of the proportional hazards model is the frailty model introduced by Vaupel
et al. (1979) and Clayton (1978). The frailty model accounts for dependent event times by
incorporating a random effect, called a frailty, that acts multiplicatively on the baseline
hazard function of the proportional hazards model (3.1). This random effect represents
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unobserved covariates that describe the correlated event times within clusters. For example,
when studying siblings the random effect represents the effect of common genetic traits
and a common childhood environment which can cause event times between siblings to be
dependent. All members of a particular cluster share these unobserved covariates and so
every member of a cluster has a common frailty effect. Event times between clusters are
assumed to be independent; therefore, frailties are independent random variables. Frailties
are also unobservable, since it is not possible to quantify the latent covariates that account
for the dependence. When clusters have only one observation, the frailty term adjusts for
individual unobserved heterogeneity.
Suppose there are i = 1, 2, . . . , n clusters where each cluster has j = 1, 2, . . . , ni obser-
vations, so that the total sample size is N =
∑n
i=1 ni. The two indices i and j denote a
unique observation from the overall sample of size N . Let Ui be an unobserved non-negative
random effect or frailty that is shared by each member of cluster i. Given Ui = ui, the
hazard function for the jth observation of the ith cluster is,
λij(t|ui) = uiλ0(t) exp(XTijβ) (3.1)
where λ0(t) is the baseline hazard function, β = (β1, β2, . . . , βp)
T is a p × 1 vector of fixed
parameters and Xij is a p× 1 vector of known covariates for the jth observation of the ith
cluster; let X be a N × p matrix whose ijth row is XTij . All covariates are assumed to be
fixed and not dependent on time.
The frailties, Ui, are non-negative, independent and identically distributed random vari-
ables with a density function having frailty parameter θ (possibly a vector) and are assumed
to remain constant over time; Wintrebert et al. (2004) and Yau and McGilchrist (1998)
investigate models with time-dependent frailty terms. The basic idea of the frailty term is
that groups or individuals who are more frail will have a large value for Ui and be more likely
to experience the event earlier, while those who are less frail will have a smaller value for
Ui and be likely to experience the event later. Conditional on the frailty term Ui, the event
times within cluster i are assumed to be independent. Event times are conditionally inde-
pendent given the frailty because frailties represent unobserved covariates and event times
conditional on covariates are assumed to be independent. In short, the frailty Ui plays two
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roles (Wu, 2010): (1) it accounts for the correlation between event times within the same
cluster and (2) it accounts for the variation in event times between different clusters. For a
homogeneous study population, Ui = 1 for all i and (3.1) reduces to the familiar proportional
hazards model.
An alternative form of (3.1) treats the frailty more like a random effect from mixed
models (McGilchrist, 1993),
λij(t|vi) = λ0(t) exp(XTijβ + vi) (3.2)
where vi = log(ui). To help distinguish between models (3.1) and models (3.2) U will be
referred to as a frailty and V will be referred to as a random effect. In (3.2), the random
effect Vi has more of a symmetric interpretation, where Vi > 0 indicates more frail clusters,
Vi < 0 less frail clusters and Vi = 0 indicates no clustering effect. Estimation in chapter 4 is
performed using (3.2), since vi can be any real number whereas ui is restricted to non-negative
values; this restriction may cause problems with convergence.
The frailty model (3.1) is relatively simple. First, it assumes that Ui is constant over time.
Thus the frailty term only represent differences between clusters at the start of the study.
Second, the model assumes that frailties act proportionally on a common baseline hazard
rate shared by every cluster. This does not allow for a lot of uniqueness between clusters since
the conditional hazard rate for each cluster follows the same general shape. Nonetheless, the
frailty model is still able to capture some of the effects of unobserved covariates providing
some understanding of what is going on. Quoting G.E. Box, “All models are wrong, some
models are useful.”
This chapter begins with a discussion of the general characteristics of frailty distributions
and highlights commonly used frailty distributions. Next, several different frailties models
are reviewed. First, the simple univariate and shared frailty models are briefly discussed.
Then section 3.4 uses correlated frailty models to model cause-specific hazard rates when
competing event times are correlated. Lastly, section 3.5 discusses the subhazard frailty
model. Both Wienke (2011) and Duchateau and Janssen (2008) are excellent resources for
frailty models.
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3.1 GENERAL CHARACTERISTICS
3.1.1 Frailty Distributions
Most often either the gamma distribution or lognormal distribution is assumed for the frailty
term. The gamma distribution is attractive for mathematical and computational reasons
and the lognormal distribution is widely used because of the link between frailty models
and generalized mixed models which assumes that random effects are normally distributed.
Other commonly used distributions are the inverse Gaussian and positive stable. Both these
distributions also share the computational benefits of the gamma distribution. Recall that
frailties are non-negative, thus the support of a frailty distribution must be non-negative.
The gamma density function with shape parameter a and scale parameter b is,
f(u) =
1
Γ(a)
baua−1e−ub (3.3)
for u ≥ 0 and a, b > 0 with E(U) = a/b and Var(U) = a/b2. This density function is
frequently assumed because the Laplace transform has a simple form which makes it easy to
calculate the marginal survival and hazard functions (section 3.1.2). Moreover the gamma
distribution is very flexible and can take a variety of shapes, Figure 3.1. In order to make
sure the frailty model is identifiable the restriction a = b is often made for the gamma
distribution. Then E(U) = 1 and Var(U) = 1/b = θ. Thus the gamma density used with
frailty models only depends on one parameter θ,
f(u) =
1
Γ(1/θ)
(1/θ)(1/θ)u1/θ−1e−u/θ (3.4)
where θ ≥ 0. It is important to note that there is no biological reason for assuming a gamma
distribution, the main advantages of assuming a gamma distribution are computational.
The lognormal frailty distribution is used because of the similarities between mixed
models and frailty models. Recall equation (3.2), λij(t|vi) = λ0(t) exp(XTijβ + vi), following
mixed model theory the random effect Vi is assumed to be normally distributed with mean
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Figure 3.1: Gamma frailty density (left) with mean 1 and variance θ and lognormal frailty
density (right) where V = log(U) has mean 0 and variance θ.
0 and variance θ. Thus the frailty U = exp(V ) is a lognormal random variable with density
function,
f(u) =
1
u
√
2piθ
exp
(
−(log(u))
2
2θ
)
(3.5)
where u ≥ 0 and θ ≥ 0. The E(U) = exp(θ/2) and Var(U) = exp(2θ)− exp(θ). Rather than
restrict E(U) = 1, to guarantee identifiability, it is more natural to assume that V ∼ N(0, θ).
Thus the expected value of a lognormal frailty U will not be one.
A disadvantage of using a lognormal frailty distribution is that there is no closed form
solution for the marginal survival function (section 3.1.2). As a result more sophisticated
numerical techniques need to be used to numerically evaluate integrals. Despite the com-
putational difficulties, Vaida and Xu (2000) prefer assuming normally distributed random
effects. Unlike gamma distributed frailties, normally distributed random effects are symmet-
ric and scale-invariant. Another advantage of lognormal distributions is that for multivariate
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frailty problems we can assume a multivariate normal distribution for the random effects V ,
which will make it easier to model the dependence between frailties, like in section 3.4.
Selecting which frailty distribution to assume depends on the purpose of the analysis
as well as available software. If the primary objective of the analysis is the association
between members of a cluster then the frailty distribution needs to be carefully considered.
Since different frailty distributions lead to noticeably different association structures within
clusters (Shih and Louis, 1995). On the other hand, if the interest is on the regression
coefficients then selecting a frailty distribution is less important. Simulation studies suggest
that misspecifying the frailty distribution has a minimal effect on the estimated regression
coefficients (Glidden and Vittinghhoff, 2004, Ha and Lee, 2003). Thus depending on the
purpose of the analysis the frailty distribution may or may not have a serious impact.
3.1.2 Frailty Density among Survivors
The frailty density f(u|θ) with parameter θ describes the frailty in the population at the
beginning of the study. For each cluster the frailty effect is assumed to remain constant
with respect to time. However, as time goes by the population at risk changes. On average,
individuals from more susceptible groups with a higher frailty will have an event earlier and
those individuals from less frail groups will have a lower frailty and experience an event later.
As a result the distribution of the frailties among survivors changes with time.
Let f(u|T > t) denote the frailty density among the survivors at time t. To illustrate how
f(u|T > t) changes with time consider a simple univariate frailty model with one observation
per cluster ni = 1 that only consists of a frailty term Ui acting multiplicatively on the baseline
hazard function λ0(t) with no covariate information. Then the conditional hazard function
for individual i is,
λi(t|ui) = uiλ0(t). (3.6)
The following results directly extend to clusters of any size. For simplicity, the subscript i
will be suppressed for the remainder of this section.
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It follows from (3.6) that the survival function for an individual conditional on the frailty
U = u is,
S(t|u) = exp
(
−
∫ t
0
λ(s|u) ds
)
= exp (−uΛ0(t)) (3.7)
where Λ0(t) =
∫ t
0
λ0(s) ds is the cumulative baseline hazard function. Currently the model
is conditional on knowing the unobservable frailties and does not represent what is actually
observed. Since the frailties are unobservable it is reasonable to integrate out the frailty
random variable and consider the population survival function S(t), the unconditional sur-
vival function for an individual randomly drawn from the population being studied. The
survival function S(t) is also referred to as the marginal survival function, while S(t|u) is
called the conditional survival function. Integrating out the frailty with respect to the frailty
distribution gives,
S(t) =
∫ ∞
0
S(t|u)f(u) du
=
∫ ∞
0
exp (−uΛ0(t)) f(u) du
= EU [exp (−uΛ0(t))]
= LU (Λ0(t)) (3.8)
where EU denotes taking the expectation with respect to the distribution of U and LU is
the Laplace transform of the frailty density function,
LU(s) = EU(e−su) =
∫ ∞
0
e−suf(u) du. (3.9)
Laplace transforms play an important role with frailty models. If the Laplace transform
of the frailty density has an explicit form then the derivatives of the Laplace transform can
be used to obtain general results (Hougaard, 1984). For example, the unconditional density
function of T is,
f(t) = −λ0(t)L′U(Λ0(t)) = −
d
dt
S(t) (3.10)
and the population or marginal hazard function of the event times are,
λ(t) = −λ0(t)L
′
U(Λ0(t))
LU(Λ0(t)) = −
d
dt
log(S(t)). (3.11)
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Moreover, the expected value and variance of the frailties can also be expressed as derivatives
of the Laplace transform of the frailty density,
E(U) = −L′U(0)
Var(U) = L′′U(0)− (L′U(0))2.
All of these calculations are easy to compute if the Laplace transform has a simple form.
Frailty distributions with an explicit Laplace transform like the gamma distribution and
inverse Gaussian distribution are often assumed because they simplify parameter estimation.
For the lognormal distribution no closed form expression of the Laplace transform exists.
As a result most procedures for fitting frailty models with a lognormal frailty distribution
require numerical integration methods to calculate the marginal survival function.
Now by Bayes’ theorem, the frailty density among the survivors at time t is,
f(u|T > t) = S(t|u)f(u)
S(t)
. (3.12)
Similarly, the frailty density of the individuals who have an event at time t is,
f(u|T = t) = f(t|u)f(u)
f(t)
. (3.13)
Suppose U follows a gamma distribution with mean 1 and variance θ (3.4). Then, the
probability of a random individual in the study population surviving until time t is given by
S(t) = L(Λ0(t)) =
(
1
1 + θΛ0(t)
) 1
θ
. (3.14)
It follows from (3.12) that the frailty density for the survivors at time t is,
f(u|T > t) = exp(−uΛ0(t))
[
u1/θ−1e−u/θ/(θ1/θΓ(1
θ
))
]
(1 + θΛ0(t))−1/θ
=
(1
θ
+ Λ0(t))
1/θ
Γ(1
θ
)
u1/θ−1 exp (−u[1/θ + Λ0(t)]) (3.15)
a gamma density with shape parameter 1/θ and scale parameter [1/θ + Λ0(t)]. In a similar
fashion, f(u|T = t) is also a gamma density with shape parameter 1/θ+1 and scale parameter
[1/θ + Λ0(t)].
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Figure 3.2: Expected frailty for events at time t and among survivors at the same time;
where U follows a gamma distribution with mean 1 and variance θ = 1 and Λ0(t) = (t/7)
3.
Then the average frailty among the survivors at time t is,
E(U |T > t) = 1
1 + θΛ0(t)
(3.16)
and the average frailty among individuals who have an event at time t is,
E(U |T = t) = 1 + θ
1 + θΛ0(t)
. (3.17)
Notice that both E(U |T > t) and E(U |T = t) decrease over time. The decrease is faster for
more heterogeneous populations (large θ) and when the event is not rare (higher cumulative
baseline hazard Λ0(t)). The individuals who survive the longest will have on average smaller
frailties than those who have an event earlier. Furthermore, E(U |T > t) is less than E(U |T =
t) for all t. Thus the individuals who have an event at time t have on average a higher frailty
than those individuals who survive beyond time t. Figure 3.2 illustrates this relationship
assuming a Weibull distribution for T with cumulative baseline hazard (t/7)3 and with θ = 1.
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Note that for any frailty distribution, the expected frailty among the survivors decreases with
time.
From (3.15) the variance of the frailties among the survivors at time t is,
Var(U |T > t) = θ
(1 + θΛ0(t))2
. (3.18)
Likewise, the variance among those who have an event at the same time is,
Var(U |T = t) = θ(1 + θ)
(1 + θΛ0(t))2
. (3.19)
Both (3.18) and (3.19) decrease over time, so it appears that the population is becoming less
heterogeneous over time. However, a normalized measure of the variance, such as the coef-
ficient of variation, should be used to describe the heterogeneity of the frailties (Hougaard,
1984). When the frailties follow a gamma distribution with mean 1 and variance θ, the
coefficient of variation among survivors at time t is,
√
Var(U |T > t)
E(U |T > t) =
√
θ. (3.20)
Thus the population does not become more homogeneous with time.
Other frailty distributions lead to different conclusions. For example, consider the inverse
Gaussian density (Hougaard, 1984),
f(u) =
( α
2piu3
)1/2
exp
(
− α
2uµ2
(u− µ)2
)
(3.21)
with u ≥ 0 and α, µ > 0; the E(U) = µ and Var(U) = µ3/α. Let µ = 1 so that Var(U) =
1/α = θ = then the coefficient of variation for the frailties among the survivors is,
√
θ√
1 + θΛ0(t)
. (3.22)
In this case, the coefficient of variation is decreasing as time increases and the population is
becoming more homogeneous over time.
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Figure 3.3: Marginal and conditional hazard functions; where U follows a gamma distribution
with mean 1 and variance θ = 1 and Λ0(t) = (t/7)
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3.1.3 Marginal and Conditional Hazard Functions
The marginal or population hazard function, λ(t), applies to the entire population, uncon-
ditional on the observation’s cluster; whereas, the conditional hazards model λ(t|u) only
applies to observations within a particular cluster. Consider the simple frailty model from
section 3.1.2,
λ(t|u) = uλ0(t).
Notice that the baseline hazard function behaves in a similar way for all clusters, if λ0(t)
is increasing then the baseline hazard increases over time for every cluster regardless of the
frailty term for that cluster. However this is not necessarly true for the population hazard
function. If the true model is the conditional hazard function then the derived population
hazard function may not behave the same, it might actually decrease when the conditional
hazard increases.
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Vaupel et al. (1979) shows that the population hazard function can be interpreted as the
weighted baseline hazard where the weights are determined by the expected frailty among
the survivors,
λ(t) =
∫ ∞
0
λ(t|u)f(u|T > t) du = λ0(t)
∫ ∞
0
uf(u|T > t) du = λ0(t)E(U |T > t). (3.23)
Since the expected frailty declines over time, hazard rates for the population will also decrease
over time. Thus it is likely that the population hazard rate will not resemble the hazard
rate of an individual from that population. Assume a gamma distribution for U then using
(3.16) the population hazard rate is,
λ(t) =
λ0(t)
1 + θΛ0(t)
. (3.24)
As in Figure 3.2, assume U follows a gamma distribution with mean 1 and variance θ = 1
and assume a Weibull distribution for T with cumulative baseline hazard rate λ0(t) = (t/7)
3.
Then, Figure 3.3 is a plot of the population hazard rate and the hazard rate conditional on
different frailty values. Notice that conditional on the frailties the hazards increase over time
while the population hazard decreases to zero. From Figure 3.3, it is clear that erroneous
conclusions can be made if decisions on an individual level are only made based on the
population hazard function; Vaupel and Yashin (1985) and Aalen (1994) give additional
examples.
3.1.4 Marginal and Conditional Hazard Ratio
Even though the proportional hazards assumption is true for the conditional hazard function
λ(t|u), this assumption may not be true for the marginal hazard function, λ(t). Consider a
simple univariate frailty model with ni = 1, where there is just one binary covariate Xi,
λi(t|ui) = uiλ0(t) exp(Xiβ). (3.25)
The following results directly extend to clusters of any size. For simplicity, the subscript i
will be suppressed for the remainder of this section.
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Figure 3.4: Marginal and conditional hazard ratios; where U follows a gamma distribution
with mean 1 and variance θ = 1, Λ0(t) = (t/7)
3 and β = 2.
Assuming the frailty model (3.25) is the true model, the marginal or population hazard
ratio is given by,
λ(t|X = 1)
λ(t|X = 0) = exp(β)
λ0(t)E(U |T > t,X = 1)
λ0(t)E(U |T > t,X = 0) . (3.26)
It is clear from the above formula that the population hazard ratio will be time dependent
except under specific circumstances. Whereas the conditional hazard ratio,
λ(t|U = u,X = 1)
λ(t|U = u,X = 0) =
λ0(t)u exp(β)
λ0(t)u
= exp(β). (3.27)
does not depend on time. Note from (3.27) that the hazard ratios for frailty models have a
cluster-specific interpretation where the hazard ratio refers to comparisons within the same
cluster where observations share the same frailty.
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To see the difference between the marginal and conditional hazard ratios, assume a
gamma distribution with mean 1 and variance θ for U (3.4). Then using (3.16) the hazard
ratio for the population is,
exp(β)
1 + θΛ0(t)
1 + θΛ0(t) exp(β)
. (3.28)
With a gamma frailty distribution, the population hazard ratio is generally time dependent
and is only independent of time if θ = 0 or β = 0. As t increases the hazard ratio decreases to
one. Like with expected frailty in section 3.1.2 the decrease in the hazard ratio is increased
for large θ, large Λ0(t) or large β. On the other hand if these factors are small then the
decrease is modest. Figure 3.4 graphs the marginal and conditional hazard ratios, assuming
a Weibull distribution for T with λ0(t) = (t/7)
3 and β = 2. It is clear from this figure that
mistakes can be made about the effects of treatment if the frailty term is ignored.
For other frailty distributions there can be even greater differences between the marginal
and conditional hazard ratios. For example, it is possible to have a crossover effect where the
population hazard ratio changes from being greater than one to less than one as time goes
on. In other words, the group that is at high risk of having an event becomes the low risk
group as time increases. Consider the compound Poisson distribution (Aalen, 1992) with
density function,
f(u) = exp
(
−α(1− γ)
(
u
µ
− 1
γ
))
× 1
pi
∞∑
κ=1
(α(1− γ))κ(1−γ)µκγ
γκ
Γ(κγ + 1)
κ!
(−u)−κγ−1 sin(κγpi) (3.29)
where u ≥ 0 and the parameters µ, α, κ > 0 and γ < 0; E(U) = καγ−1 and Var(U) =
κ(1 − γ)αγ−2. An interesting feature of this distribution is that it allows for a subgroup of
observations that never experience the event, a subgroup where the frailty is zero. Making
the usual restrictions E(U) = 1 and Var(U) = 1−γ
α
= θ, the population hazard ratio is,
λ(t|X = 1)
λ(t|X = 0) = e
β
(
1 + θ
1−γΛ0(t)
)1−γ
(
1 + θ
1−γΛ0(t)e
β
)1−γ . (3.30)
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When t = 0 the hazard ratio is eβ and converges towards eγβ as t → ∞. Under this
distribution it is possible to have a crossover effect of the hazard ratios. For example,
assuming a Weibull distribution for T with Λ0(t) = (t/7)
3, β = 2, variance θ = 1 and
γ = −0.5, the hazard ratio at t = 0 is exp(β) = 7.4 while when t = 10 it is 0.62 and
ultimately converges to 0.37 when t =∞. Thus the high risk group at the beginning of the
study becomes the low risk group by the end of the study.
3.2 UNIVARIATE FRAILTY MODEL
If there is only one observation for each cluster, ni = 1 for all i, then (3.1) is the hazard
function for a univariate frailty model,
λi(t|ui) = uiλ0(t) exp(XTi β) (3.31)
where the subscript j is no longer necessary. This model is used to account for unobserved
heterogeneity that can be the result of not including important covariates in the analysis.
With a homogeneous population all individuals have the same risk of experiencing the event,
thus it is reasonable to assume a common hazard function for everyone. However, if impor-
tant covariates are not included in the analysis then the population is heterogeneous and
individuals have different risks of experiencing the event (Wienke, 2011). In this case, a
different hazard function needs to be fit for each individual; including the frailty effect Ui in
(3.31) changes the hazard function for each individual and accounts for the heterogeneity.
In a heterogeneous study population there are individuals with a high risk of failure
and there are those individuals with a low risk of having an event. As time goes by, the
individuals that remain in the study tend to be of lower risk. Thus estimates of the individual
hazard rate without considering the frailty term will increasingly underestimate the hazard
rate as time goes by (section 3.1.3). Therefore, to have unbiased estimates it is important
to include a frailty term to account for unobserved heterogeneity.
The EM algorithm (Nielsen et al., 1992, Klein, 1992, Vaida and Xu, 2000), the penalized
partial likelihood method (Therneau et al., 2003) and more recently hierarchical likelihood
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(Ha et al., 2010) can all be used to estimate the univariate frailty model. Of these three
approaches, simulation studies suggest that under certain situations the method using hi-
erarchical likelihood will give the least biased estimates (Ha et al., 2010). To guarantee
identifiability of the parameters when fitting the model it is necessary to have a sufficiently
variable predictor; for the shared frailty model (section 3.3) within-cluster associations pro-
vide sufficient information to identify the parameters (Barker and Henderson, 2005). This
work does not focus on univariate frailty models, for a more complete discussion of this
model see Wienke (2011).
3.3 SHARED FRAILTY MODEL
When the cluster sizes are greater than 1, ni > 1, (3.1) is the hazard function for the shared
frailty model,
λij(t|ui) = uiλ0(t) exp(XTijβ). (3.32)
The shared frailty model is used to model dependent event times. Shared frailty models
are based on two main assumptions (Huang and Wolfe, 2002). First, the frailty effect Ui is
shared by each member of the cluster. Second, within each cluster censoring times and event
times are independent.
There are several approaches for fitting the shared frailty model. Since the frailties are
considered unobserved covariates, Nielsen et al. (1992) and Klein (1992) proposed using
the EM algorithm assuming a gamma distribution for Ui to maximizes the observed data
likelihood or marginal likelihood where the frailty is integrated out,
Lm(β, θ, λ0) =
∫
L(β, λ0|u)f(u|θ) du (3.33)
where f(u|θ) is the frailty density function and
L(β, λ0|u) =
∏
ij
(
uiλ0(tij) exp(X
T
ijβ)
)δij
exp
(−uiΛ0(tij) exp(XTijβ)) (3.34)
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is the likelihood function conditional on the frailties u = (u1, u2, . . . , un), where tij is the
observed event time and δij is the event indicator (1 if an event occurs and 0 otherwise) for
the jth observation in cluster i.
McGilchrist and Aisbett (1991) and McGilchrist (1993) developed a procedure using the
partial likelihood and assuming a lognormal frailty distribution. More recently, Vaida and
Xu (2000), Garnst et al. (2009) and Ripatti et al. (2002) used the EM algorithm to fit
models with multivariate lognormal frailties. Ripatti and Palmgren (2000) and Therneau
et al. (2003) present a penalized partial likelihood (PPL) approach; for gamma frailties
the PPL estimator is the exact same as the EM algorithm and for lognormal frailties the
PPL estimator is equivalent to the maximum likelihood estimator presented by McGilchrist
(1993). Liu and Huang (2008) has suggested using Gaussian quadrature to fit shared as well
as joint frailty models assuming a piecewise constant baseline hazard function.
Ha et al. (2001) and Ha and Lee (2003) extended the h-likelihood (Lee and Nelder,
1996) techniques to estimating regression coefficients under frailty models with gamma and
lognormal frailties for parametric and non-parametric baseline hazard functions. The h-
likelihood method provides a unified procedure for fitting models that contain both fixed
parameters and unobserved random effects. Often, the random effects are integrated out
and the marginal likelihood is used for inference using the EM algorithm. A disadvantage
of the EM algorithm is that the procedure can be computationally intensive if there is no
closed form expression of the marginal survival function, such as for the lognormal frailty
distribution. In this case, Markov chain Monte Carlo methods are used to numerically
integrate the conditional expectation of the frailty given the observed data. Moreover the
estimated standard errors of the regression coefficients are not readily available. Instead they
need to be computed using Louis’ formula (Louis, 1982). The advantage of the h-likelihood is
that it does not require any integration because the h-likelihood includes the random effects
in the estimation procedure and does not use the marginal distribution. Since the frailties
are not integrated out, this approach also allows for direct inference on the random effects.
It was shown in Ha et al. (2001) that for a gamma frailty distribution, the h-likelihood
estimates of β and v conditional on θ are the same as the estimates returned by the EM
algorithm.
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The penalized partial likelihood (PPL) and h-likelihood both give the same estimates
of β and v for fixed θ. The difference between the two methods is in the estimation of
θ. For lognormal frailty models PPL uses an approximate marginal maximum likelihood
estimator for θ. Whereas h-likelihood uses an approximate restricted likelihood estimator
for θ. Furthermore the h-likelihood uses a higher order approximation which can lead to less
biased estimates of the frailty parameters θ (Ha and Lee, 2003).
3.4 CAUSE-SPECIFIC HAZARD FRAILTY MODEL
The shared frailty model assumes that within clusters censoring times are independent of
event times. When competing risks are present this assumption is no longer reasonable,
since subjects who experience a competing risks event are censored informatively. To avoid
biased results the information from informatively censored subjects needs to be included.
The cause-specific hazard frailty model is a generalization of the shared frailty model that
allows for competing risks as well as independent censoring. A similar model was introduced
by Huang and Wolfe (2002). Suppose there are k = 1, 2, . . . ,m event types and assume Vi is
a random variable from a univariate distribution with parameter θ. Then the cause-specific
hazard function conditional on the frailty for the jth observation in cluster i who failed from
cause k is,
λijk(t|vi) = λ0k(t) exp(XTijβk + vi) (3.35)
where λ0k(t) is the baseline hazard function for event type k and βk = (βk1, βk2, . . . , βkp)
T is
a p× 1 vector of fixed parameters for event k. Let β = (β1, β2, . . . , βm) be a mp× 1 vector of
all the regression coefficients for all event types. Similarly let λ0 = (λ01, λ02, . . . , λ0m) denote
the collection of all baseline hazard functions. If there is only one event type m = 1 then
(3.35) is simply the shared frailty model (3.32).
Model (3.35) simply accounts for correlated event times but there are some limitations to
this model which may cause it to be a poor fit in some situations. First, the model assumes
that the effect of the frailty is the same for every type of event within a cluster. However, this
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assumption may not be reasonable. There can easily be instances where on average, subjects
who experience one type of event are more frail and subjects who experience a second event
type are less frail.
Another limitation is that (3.35) only allows for positive association within clusters. If
the true value of the frailty is less than one then everyone in the cluster experiences an
event of any type at an earlier time compared to when the frailty is greater than one where
everyone in the cluster experiences any event type at a later time. Thus there is a positive
association between observations within a cluster. However there may be cases where there
is actually a negative association within a cluster. For example, reducing the risk of dying
from cancer can increase the risk of dying from some other disease.
To correct for these limitations, a variation of the bivariate frailty model (Xue and
Brookmeyer, 1996) is used in which there is a random effect for each event type,
λijk(t|vi) = λ0k(t) exp(XTijβk + vik), (3.36)
where vik is the random effect for event k in cluster i. With this model each cluster will have
m random effects, one for each event type.
A multivariate distribution needs to be assumed for the random effects, (Vi1, Vi2, . . . , Vim).
A natural choice is the multivariate normal distribution with mean 0 and m×m covariance
matrix Σ. Different covariance patterns can be assumed for Σ, such as for m = 3,
1. Independent, no correlation between event types
Σ =

σ11 0 0
0 σ22 0
0 0 σ33

2. Exchangeable, correlation is the same between every event type
Σ =

σ11 ρσ11σ22 ρσ11σ33
ρσ11σ22 σ22 ρσ22σ33
ρσ11σ33 ρσ22σ33 σ33

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3. Unstructured, separate correlation between every event type
Σ =

σ11 ρ12σ11σ22 ρ13σ11σ33
ρ12σ11σ22 σ22 ρ23σ22σ33
ρ13σ11σ33 ρ23σ22σ33 σ33

It is also possible to assume a constant variance σ11 = σ22 = σ33 for all event types rather
than the more general structures given above.
An advantage of a multivariate normal frailty distribution is that it makes it easy to
estimate the correlation between the random effects for different event types by estimating
the variance components of Σ. This also provides some insight into the association between
different types of events. If there is a strong association between two random effects then it
is reasonable to assume that there is also a strong association between the two corresponding
event types. A positive (negative) correlation indicates that observations with a large random
effect for one event type will also have a large (small) random effect for a different event
type. Thus their risk for a different event will be high (low), because large (small) random
effects increase (decrease) the risk of failure for a cluster.
Since there is an association between the random effects it is not possible to model each
event type separately as is normally done when modeling the cause-specific hazard rates
without clustering. Instead the effects for both event types as well as all of the random
effects need to be estimated jointly. Of course if the random effects are independent then
there are no competing risks and the shared frailty model can be fit for each event type.
For the jth observation in the ith cluster, let Tijk, k = 1, . . . ,m denote the time to event
for event type k and let Cij denote the independent censoring time. Then the observed event
time is Tij = min(Tij1, Tij2, . . . , Tijm, Cij) and define the event indicator δijk = 1 if Tij = Tijk
and 0 otherwise. Then the conditional likelihood for cluster i given the frailty vik is
Li(β, λ0|vik) =
m∏
k=1
ni∏
j=1
[
λ0k(tij)e
XTijβk+vik
]δijk
exp
(
−Λ0k(tij)eXTijβk+vik
)
. (3.37)
The conditional likelihood for model (3.35) is very similiar. Notice that the above notation
can be used for clustered individuals as well as recurrent event times and is general enough
to have recurrent event times with different event types.
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Like all frailties models the effects of the coefficients β have a cluster-specific interpre-
tation. In the presence of competing risks the effects of the cause-specific hazard frailty
model represent the pure effect when the other types of competing events are removed and
no longer exist. This approach can be useful for understanding the biological process for
a specific outcome. However in a clinical setting this interpretation is not very helpful. In
this case it would be more useful to know the effect of the covariate in the presence of other
competing risks. This kind of interpretation is given by the subhazard frailty model.
3.5 SUBHAZARD FRAILTY MODEL
An alternative approach for modeling competing risks data is to look at the effect of the
covariates on the cumulative incidence function by modeling the subhazard function (Fine
and Gray, 1999). This approach estimates the probability of an event of interest for various
values of covariates when there are competing risks. Depending on the purpose of the
analysis this interpretation can be more appropriate than using the cause-specific hazard
frailty, which estimates the covariate effect assuming the other event types are inoperative.
Frailty terms were first added to subhazard models by Katsahian et al. (2006) to account
for clustering in multi-center clinical trials. The subhazard frailty model is defined using the
hazard function of the subdistribution,
γijk(t|vik) = γ0k(t) exp(XTijβk + vik) (3.38)
where γ0k is the baseline subhazard function. It is possible to assume a multivariate distri-
bution for the frailties like in the previous section and estimate the covariates effects jointly
for all event types. However, this work will follow Katsahian et al. (2006) and only model
the subhazard for the event of interest, when k = 1. This model implicitly assumes that the
frailty effect for the event of interest is independent of the frailty effects for the other types
of events. Since the subhazard frailty model only considers one event type the subscript k
will not be used. Also following Katsahian et al. (2006) assume the random effect Vi is a
normal random variable with mean 0 and variance θ.
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Let Tij denote the observed event time for the jth observation in the ith cluster and let
δij define the corresponding event indicator where δij = 1 if the event of interest occurred
and 0 otherwise. Also let Zij = (Zij1, Zij2, . . . , Zijn)
T denote a cluster indicator vector where
Zijq = 1 if i = q and 0 otherwise. For a vector of frailties, v = (v1, v2, . . . , vn) it follows that
vi = Z
T
ijv. Then the form of the conditional partial likelihood for the event of interest k = 1
given v is,
L1(β|v) =
n∏
i=1
ni∏
j=1
(
exp(XTijβ + Z
T
ijv)∑
r∈Rij wij(tr) exp(X
T
r β + Z
T
r v)
)δij
. (3.39)
This partial likelihood resembles the partial likelihood used for the proportional hazards
model with two notable exceptions. First, the risk set Rij is all individuals who have not
experienced an event by time tij and those who experienced a competing event by time tij,
Rij = {r : (Tij ≤ Tr) ∪ (Tij > Tr ∩ δij = 0)} . (3.40)
Note that both ij and r denote a single observation from the total sample size N .
Second, there are weights wij(tr) are defined as,
wij(tr) =
Gˆ(tr)
Gˆ(min(tr, tij))
(3.41)
where Gˆ is the Kaplan-Meier estimator of the survival function for the censoring distribution;
the estimator is calculated treating censored observations as event times and event times as
censored observations, i.e. by using the data {Tij, 1 − δij}. If there is no censoring then
wij(tr) = 1 for all r.
When censoring is present, the weights equal one if individuals have not had an event. For
individuals who failed from a competing event, the weights decrease over time. Therefore,
individuals who have not failed fully contribute to the partial likelihood, while those who
failed from a competing cause only partially contribute to the partial likelihood. Their
contribution is weighted according to their probability of being censored. Ideally, they should
only remain in the risk set until they are censored, but the independent censoring time is
precluded by the occurrence of the competing event. When a subject experiences the event of
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interest or is right censored they are no longer in the risk set and do not have any additional
contribution to the partial likelihood.
Katsahian et al. (2006) first proposed an estimation procedure adapted from McGilchrist
(1993) that uses the restricted maximum likelihood approach. Later Katsahian and Boudreau
(2011) proposed another estimation procedure that uses the PPL approach. An advantage
of this recent method is that it can be done using existing software. H-likelihood and PPL
both give the same estimates of β and v for fixed θ (Ha and Lee, 2003). Since h-likelihood
uses a higher order approximation to estimate θ it is possible that h-likelihood will give more
accurate estimates of the frailty parameter θ for the subhazard frailty model compared to
the PPL method proposed by Katsahian and Boudreau (2011). This will be investigated by
extensive simulations in Chapter 5.
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4.0 HIERARCHICAL LIKELIHOOD
Lee and Nelder (1996) first proposed using the hierarchical likelihood (h-likelihood) to fit
hierarchical generalized linear models. The h-likelihood method provides a unified procedure
for fitting models that contain both fixed parameters and unobserved random effects. The
biggest advantage of h-likelihood is that it does not require any integration, which can often
be a computational hurdle depending on the model and estimation method.
This chapter derives the h-likelihood estimators for the cause-specific hazard frailty model
and the subhazard frailty model assuming either a univariate or multivariate normal distri-
bution for the random effects. First sections 4.1 and 4.2 derive the estimation procedure
for the cause-specific hazard frailty model. Next section 4.3 discusses using h-likelihood to
fit the subhazard frailty model. Finally, section 4.4 discusses techniques for inference and
model selection.
Given the similarities between fitting a shared frailty model, cause-specific hazard frailty
model and subhazard frailty model it is possible to write a general program that will fit each
model. The appendix contains an R program that performs the estimation and inference
discussed in this chapter (R Development Core Team, 2010).
4.1 ESTIMATING THE CAUSE-SPECIFIC HAZARD MULTIVARIATE
FRAILTY MODEL
The purpose of this section is to derive the h-likelihood estimators of the fixed effects β and
the frailty parameter θ as well as predict the random effects v for the semiparametric cause-
specific hazard frailty model (3.36), where the functional form of the baseline hazard is not
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specified and the random effects are multivariate normal. The following estimation procedure
is similar to Ha et al. (2011) who analyzed multi-center clinical trial data accounting for the
between-center variation and the treatment effect across centers by assuming a bivariate
normal frailty distribution. For m = 1 this estimation method reduces to the shared frailty
case (Ha et al., 2001, Ha and Lee, 2003). To simplify the notation, assume there are just
two event types k = 1, 2, the results easily generalize to m event types.
First, define the h-likelihood function. Suppose there are i = 1, 2, . . . , n clusters where
each cluster has j = 1, 2, . . . , ni observations, so that the total sample size is N =
∑n
i=1 ni.
The two indices i and j denote a unique observation from the overall sample of size N .
Following Ha et al. (2001), the contribution of the jth observation in the ith cluster to the
h-likelihood for event k is given by the log of the joint density function of (Tij, δijk, vik)
written as a function of the parameters for event k, (βk, λ0k, θ),
hijk = hijk(βk, λ0k, θ; tij, δijk, vik) = log [fijk(tij, δijk; βk, λ0k|vik)fi(vi; θ)] (4.1)
where fijk is the conditional density function of Tij and δijk given Vik = vik with parameters
(βk, λ0k) and fi is the density function of Vi = (Vi1, Vi2) with parameter θ. The conditional
density function of (Tij, δijk) given Vik = vik is
fijk(tij, δijk; βk, λ0k|vik) =
[
λ0k(tij)e
XTijβk+vik
]δijk
exp
(
−Λ0k(tij)eXTijβk+vik
)
. (4.2)
Assume Vi = (Vi1, Vi2) follows a bivariate normal distribution with mean 0 and covariance
matrix Σ. Then the density function is,
fi(vi) =
1
(2pi)|Σ|1/2 exp
(
−1
2
vTi Σ
−1vi
)
. (4.3)
Let θ = (σ11, σ22, σ12)
T be the parameter vector for fi(vi) that contains the variance com-
ponents of Σ. Notation note, it will be helpful to distinguish between random effects
associated with a cluster and random effects for a particular event type. So, let Vi =
(Vi1, Vi2)
T denotes the random effects vector for both event types for cluster i and let
Vk = (V1k, V2k, . . . , Vnk)
T denote a n-dimension vector of the random effects from all clus-
ters just for event k; the random effect Vik is the effect for event k in cluster i. Also, let
V = (V11, V21, . . . , Vn1, V12, V22, . . . , Vn2)
T be a 2n-dimensional vector of all random effects,
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for all clusters and event types. Notice that the random effects are arranged by event type
so that all of the random effects for the same event type are adjacent. The structure of V is
important later on in this chapter only because it determines how the observed information
matrices are structured. Other forms of V are allowable, but will require rearranging terms.
Similarly, let β = (β1, β2)
T be a vector of regression coefficients for both event types and let
λ0 = (λ01, λ02) be a collection of all the baseline hazards.
Since event times within a cluster are conditionally independent given the frailty Vi = vi
and the frailties Vi are independent and identically distributed random variables, the h-
likelihood for the cause-specific hazard frailty model is,
h(β, λ0, v, θ) =
∑
ijk
hijk =
∑
ijk
lijk(βk, λ0k; tij, δijk|vik) +
∑
i
li(θ; vi) (4.4)
where
lijk(βk, λ0k; tij, δijk|vik) = δijk
(
log λ0k(tij) + x
T
ijβk + vik
)− Λ0k(tij) exp (xTijβk + vik)
is the log of the conditional density function for Tij and δijk given Vik = vik and
li(θ; vi) = − log(2pi)− 1
2
log |Σ| − 1
2
vTi Σ
−1vi
is the log of the bivariate normal density function for Vi with parameter θ.
No parametric form is assumed for the baseline hazard function λ0k(t). Instead assume
that the cumulative baseline hazard function for event type k is a step function with jumps
at the observed event times,
Λ0k(t) =
∑
r : t(kr)≤t
λ0kr (4.5)
where t(k1) < t(k2) < . . . < t(kDk) denote the Dk ordered unique event times for type k events
among all of the tij’s that refer to the time of a type k event and λ0kr = λ0k(t(kr)). Also let
dkr be the number of events that occur at time t(kr).
As the number of type k events increases, the number of nuisance parameters, λ0kr,
r = 1, 2, . . . , Dk, also increases. This requires the estimation of a high dimensional baseline
hazard function λ0k. Therefore, following Ha et al. (2001) the profile h-likelihood is used
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where λ0k and Λ0k are removed. Murphy and van der Vaart (2000) give a general justification
for using a semi-parametric profile likelihood for statistical inference.
To calculate the profile h-likelihood, first rewrite the h-likelihood (4.4) so that it will be
easier to differentiate with respect to λ0kr for fixed βk, vk and θ. Let Zij=(Zij1, Zij2, . . . , Zijn)
T
be a n× 1 cluster indicator vector where Zijq = 1 if i = q and 0 otherwise; let Z be a N × n
matrix whose ij row is ZTij . Then vik = Z
T
ijvk for any j. Replace vik with Z
T
ijvk in (4.4) and
sum over the unique event times for each event type. Then by using (4.5) the h-likelihood
(4.4) can be rewritten as,
h =
2∑
k=1
[
Dk∑
r=1
dkr log λ0kr+S
T
Xkrβk+S
T
Zkrvk−λ0kr
∑
ij∈Rkr
exp
(
XTijβk + Z
T
ijvk
)]
+
n∑
i=1
li(θ; vi) (4.6)
where, STXkr =
∑
ij∈Dkr X
T
ij and S
T
Zkr =
∑
ij∈Dkr Z
T
ij are the sums of the vectors X
T
ij and Z
T
ij
over the set Dkr = {ij : δijk = 1 and tij = t(kr)} of all individuals who have a type k event
at time t(kr) and Rkr = {ij : tij ≥ t(kr)} is the risk set at time t(kr), this is the set of all
individuals who are still at risk to experience an event.
Using an approach similar to Johansen (1983), by fixing βk, vk and θ and maximizing
(4.6) as a function of λ0kr gives the nonparametric maximum hierarchical likelihood estimator
of λ0kr,
λˆ0kr =
dkr∑
ij∈Rkr exp(X
T
ijβk + Z
T
ijvk)
. (4.7)
Thus, Λˆ0k(t) =
∑
r: ykr≤t λˆ0kr is an extension of the Breslow (1974) estimator of the baseline
cumulative hazard function. Replacing λ0kr with λˆ0kr in (4.6) gives the profile h-likelihood
as a function of β, v, and θ only,
hp(β, v, θ) =
∑
kr
STXkrβk+S
T
Zkrvk−dkr log
( ∑
ij∈Rkr
exp
(
XTijβk+Z
T
ijvk
))−dkr+ n∑
i=1
li(θ; vi). (4.8)
The maximum hierarchical likelihood estimators (MHLE) of β and v are found by maxi-
mizing the profile h-likelihood for fixed θ using the Newton-Raphson method (Tanner, 1996);
an iterative procedure that uses the gradient vector and observed information matrix to ap-
proximate the points that maximize a likelihood function. In this case, starting at initial
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values βˆ(0) and vˆ(0) the approximate maximums are updated iteratively until convergence is
achieved by,
 βˆ(i+1)
vˆ(i+1)
 =
 βˆ(i)
vˆ(i)
+


−∂2hp
∂β2
−∂2hp
∂β∂v
−∂2hp
∂v∂β
−∂2hp
∂v2

−1
∂hp
∂β
∂hp
∂v


∣∣∣∣∣∣∣∣∣
(β, v) = (βˆ(i), vˆ(i))
(4.9)
where βˆ(i) and vˆ(i) represent the estimates of β and v at the ith iteration. Reasonable starting
values for βˆ(0) = (βˆ
(0)
1 , βˆ
(0)
2 )
T are the estimates from the cause-specific hazard model for each
event type with no random effects. A possible starting value for vˆ(0) is a random sample of
size n from the bivariate normal distribution (4.3) with θ = θˆ(0), where θˆ(0) are the initial
variance components. Unfortunately, there is no good way to select appropriate starting
values for θ, so different values will need to be tried.
First the elements of the gradient vector (∂hp/∂β, ∂hp/∂v)
Tare calculated. The kth ele-
ment of ∂hp/∂β = (∂hp/∂β1, ∂hp/∂β2)
T is the derivative of hp with respect to the regression
coefficients for event k,
∂hp
∂βk
=
∑
ij
Xijδijk −XijΛˆ0k(tij) exp
(
XTijβk + Z
T
ijvk
)
(4.10)
and ∂hp/∂v = (∂hp/∂v1, ∂hp/∂v2)
T is the derivative of hp with respect to the random effects
for each event type where for event k,
∂hp
∂vk
=
∑
ij
Zijδijk − ZijΛˆ0k(tij) exp
(
XTijβk + Z
T
ijvk
)− n∑
i=1
vi • (σkk, σ12) (4.11)
where • denotes the inner product of two vectors.
Calculating the estimators will be much easier if matrices are used instead of summations.
The following matrices and notation are used for the remainder of this section. Let Rk =
(R1, R2, . . . , RDk) be a N×Dk at risk indicator matrix where the ijth element in column r is
one if tij ≥ tkr and zero otherwise. Define Ek as aN×1 type k event indicator vector with ijth
element δijk. Let Mk be a N ×N diagonal matrix with elements Λˆ0k(tij) exp(XTijβk +ZTijvk),
let Nk be a N×N diagonal matrix with elements exp(XTijβk+ZTijvk) and let Ck be a diagonal
Dk×Dk matrix where the rth element is λˆ0kr/dkr. Finally, let In be a n×n identity matrix
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and let ⊗ denote the Kronecker product. Recall that X is a N × p matrix of p covariates
and Z is a N × n cluster indicator matrix.
Using this notation the gradient vector can be rewritten in a more compact form. First
equation (4.10) can be expressed as
∂hp
∂βk
= XT (Ek −Mk). (4.12)
Second the derivative of hp with respect to all random effects v is,
∂hp
∂v
=
 ZT (E1 −M1)
ZT (E2 −M2)
− (Σ−1 ⊗ In). (4.13)
Next the observed information matrix H of β and v for fixed θ is calculated. First, define
X, Z and W as block diagonal matrices such that,
X =
 X 0
0 X
 , Z =
 Z 0
0 Z
 and W =
 W1 0
0 W2
 (4.14)
where 0 is a conformable matrix of zeros and Wk = Wk(βk, vk) = Mk −NkRkCk(RkNk)T for
k = 1, 2. Then the observed information matrix H is a large (mp+mn)× (mp+mn) matrix
defined as,
H = H(β, v, θ) =
 XTWX XTWZ
ZTWX ZTWZ+Q
 . (4.15)
where the elements XTWX, XTWZ, ZTWX and ZTWZ are also block diagonal matrices
that correspond to partitions of H. That is,
−∂2hp
∂β2
= XTWX
−∂2hp
∂β∂v
= XTWZ
−∂2hp
∂v∂β
= ZTWX
−∂2hp
∂v2
= ZTWZ+Q
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where Q is a n×n matrix that is the negative second derivative of the log of the joint density
function for all random effects with respect to the vector v,
Q(v, θ) = − ∂
2
∂v2
n∑
i=1
li(θ; vi) = Σ
−1 ⊗ In. (4.16)
The next step is to find the MHLE of θ by maximizing Lee and Nelder (1996) adjusted
profile h-likelihood (Ha et al., 2001, Ha and Lee, 2003),
hA(θ) =
[
hp − 1
2
log(det(H/2pi))
]∣∣∣∣
(β, v) = (βˆ(θ), vˆ(θ))
(4.17)
given βˆ = βˆ(θ) and vˆ = vˆ(θ), the current estimates of β and v conditional on θ. The
adjusted profile h-likelihood is used to approximate the restricted likelihood of θ that takes
into account the estimation of β and v. The Newton-Raphson method is also used to find
θˆ the MHLE of θ. This requires finding the first and second derivatives of hA with respect
to every variance component of θ = (σ11, σ22, σ12)
T ; let θq and θs denote the qth and sth
components of θ respectively, for q, s = 1, 2, 3. Two identities from matrix calculus will be
useful here (Searle et al. (1992) appendix M). For a matrix A and scalar x,
∂
∂x
log |A| = trace
(
A−1
∂A
∂x
)
∂A−1
∂x
= −A−1∂A
∂x
A−1.
Using the properties of determinants (4.17) can be rewritten as
hA = hˆp − 1
2
log(det(Hˆ)) +
(p+ n)
2
log(2pi) (4.18)
where hˆp = hp(βˆ(θ), vˆ(θ), θ) and Hˆ = H(βˆ(θ), vˆ(θ), θ) are the profile h-likelihood and ob-
served information matrix evaluated at the current estimates of β and v, respectively. Then
using the above results from matrix calculus, the qth component of the gradient vector
∂hA/∂θ is
∂hA
∂θq
=
∂hˆp
∂θq
− 1
2
trace
(
Hˆ−1
∂Hˆ
∂θq
)
. (4.19)
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Furthermore, the element in row q and column s of the 3 × 3 observed information matrix
∂2hA/∂θ
2 for the frailty parameter θ is
− ∂
2hA
∂θq∂θs
= − ∂
2hˆp
∂θq∂θs
+
1
2
trace
(
−Hˆ−1∂Hˆ
∂θq
Hˆ−1
∂Hˆ
∂θs
+ Hˆ−1
∂2Hˆ
∂θq∂θs
)
. (4.20)
Partial differentiation of a multivariate function with respect to one variable assumes that
the remaining variables of the function are held constant. Since βˆ(θ) and vˆ(θ) are functions
of θ, it is not appropriate to just use partial derivatives in (4.19) and (4.20). Instead the
total derivative should be used. Consider the total derivative of hA with respect to θq,
∂hA
∂θq
=
∂hA
∂θq
+
(
∂hA
∂β
∣∣∣∣
β=βˆ
)
∂βˆ
∂θq
+
(
∂hA
∂v
∣∣∣∣
v=vˆ
)
∂vˆ
∂θq
. (4.21)
The total derivative calculates the derivative of hA with respect to θq where the other ar-
guments of hA, βˆ(θq) and vˆ(θq), are allowed to depend on θq; they do not have to remain
constant.
Originally, Lee and Nelder (1996) and Ha et al. (2001) ignored ∂βˆ/∂θq and ∂vˆ/∂θq
when differentiating hˆp and Hˆ with respect to θ because the parameters are asymptotically
orthogonal (Lee and Nelder, 1996). However this approach does not work in some cases
such as data with binary covariates and small cluster sizes. Following Ha and Lee (2003),
∂βˆ/∂θ is ignored because there is an indirect dependency between βˆ and θq whereas ∂vˆ/∂θq
is included because there is a direct dependency between vˆ and θq; this is clear from (4.12)
and (4.13).
Let τ = (β, v) and let τˆ = τˆ(θ) = (βˆ(θ), vˆ(θ)). First calculate the derivatives in (4.19).
Since ∂hp/∂v|τ=τˆ = 0 the total derivative of the first term ∂hˆp/∂θq is,
∂hˆp
∂θq
=
∂hp
∂θq
∣∣∣∣
τ=τˆ
+
(
∂hp
∂v
∣∣∣∣
τ=τˆ
)(
∂vˆ
∂θq
)
=
∂hp
∂θq
∣∣∣∣
τ=τˆ
=
n∑
i=1
∂li(θ; vˆi)
∂θq
=
n∑
i=1
−1
2
trace
(
Σ−1Σ′q
)
+
1
2
vˆTi
(
Σ−1Σ′qΣ
−1) vˆi (4.22)
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where Σ′q = ∂Σ/∂θq.
The derivative of the second term ∂Hˆ/∂θq in (4.19) is more complicated,
∂Hˆ
∂θq
=
∂H
∂θq
∣∣∣∣
τ=τˆ
+
(
∂H
∂v
∣∣∣∣
τ=τˆ
)(
∂vˆ
∂θq
)
. (4.23)
The term ∂vˆ/∂θq is calculated following Lee et al. (2006). From hp given θq let vˆ(θq) be the
solution to g(θq) = ∂hp/∂v|τ=τˆ = 0. Then,
∂2g(θq)
∂θq
=
∂hp
∂v∂θq
∣∣∣∣
τ=τˆ
+
(
∂2hp
∂v2
∣∣∣∣
τ=τˆ
)(
∂vˆ
∂θq
)
= 0 (4.24)
Solving for ∂vˆ/∂θq gives a 2n× 1 vector,
∂vˆ
∂θq
=
(
−∂
2hp
∂v2
∣∣∣∣
τ=τˆ
)−1(
∂2hp
∂v∂θq
∣∣∣∣
τ=τˆ
)
=
(
ZTWˆZ+Q
)−1 ([(−Σ−1Σ′qΣ−1)⊗ In] vˆ) (4.25)
where Wˆ is W evaluated at (βˆ, vˆ, θ); that is, when Wk = Wk(βˆk, vˆk, θ) = Wˆk. Now since X
and Z are constant matrices that have no dependence on θ it follows that the total derivative
of ∂Hˆ/∂θq is,
∂Hˆ
∂θq
=
 XTWˆ′qX XTWˆ′qZ
ZTWˆ′qX Z
TWˆ′qZ+Q
′
q
 . (4.26)
where Wˆ′q = ∂Wˆ/∂θq and Q
′
q = ∂Q/∂θq. Based on the structure of W, Wˆ
′
q is found by
finding ∂Wˆk/∂θq. Since Wˆk does not depend on θ the total derivative of Wˆk is,
Wˆ ′kq =
∂Wˆk
∂θq
=
∂Wk
∂θq
∣∣∣∣
τ=τˆ
+
(
∂Wk
∂vk
∣∣∣∣
τ=τˆ
)(
∂vˆk
∂θq
)
=
(
∂Wk
∂vk
∣∣∣∣
τ=τˆ
)(
∂vˆk
∂θq
)
. (4.27)
The ∂Wk/∂vk is found by differentiating Wk(βk, vk) = Mk − NkRkCk(RkNk)T with respect
to vk. Given the structure of v defined earlier, ∂vˆ1/∂θq is the first n elements of the vector
∂vˆ/∂θq and ∂vˆ2/∂θq are the last n elements. Since Q does not depend on v the total derivative
is not needed to find ∂Q/∂θq so,
Q′q =
∂Q
∂θq
=
(−Σ−1Σ′qΣ−1)⊗ In. (4.28)
Using (4.28) there is a slightly simpler expression for ∂vˆ/∂θq =
(
ZTWˆZ+Q
)−1
+Q′qvˆ.
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The next step is to calculate the terms in the observed information (4.20). First,
− ∂
2hˆp
∂θq∂θs
= − ∂
2hp
∂θq∂θs
∣∣∣∣
τ=τˆ
−
(
∂2hp
∂v∂θs
∣∣∣∣
τ=τˆ
)(
∂vˆ
∂θs
)
=
n∑
i=1
−∂
2li(θ; vˆi)
∂θq∂θs
− (Q′qvˆ)( ∂vˆ∂θs
)
=
n∑
i=1
(
1
2
trace
(
Σ−1Σ′sΣ
−1Σ′qΣ
−1)+ 1
2
vˆTi
(
Σ−1Σ′sΣ
−1Σ′qΣ
−1) vˆi
+
1
2
vˆTi
(
Σ−1Σ′qΣ
−1Σ′sΣ
−1) vˆi)−Q′qvˆ( ∂vˆ∂θs
)
. (4.29)
The last term needed to calculate (4.20) is,
∂2Hˆ
∂θq∂θs
=
 XTWˆ′′qsX XTWˆ′′qsZ
ZTWˆ′′qsX Z
TWˆ′′qsZ+Q
′′
qs
 (4.30)
where,
Q′′qs =
∂2Q
∂θq∂θs
=
(
Σ−1Σ′sΣ
−1Σ′qΣ
−1 + Σ−1Σ′qΣ
−1Σ′sΣ
−1)⊗ In (4.31)
and Wˆ′′qs = ∂Wˆ
′
q/∂θs. Like earlier, Wˆ
′′
qs is found by finding ∂
2Wˆk/∂θq∂θs for k = 1, 2,
Wˆ ′′kqs =
∂2Wˆk
∂θq∂θs
=
[(
∂2Wk
∂v2k
∣∣∣∣
τ=τˆ
)
∂vˆk
∂θq
]
∂vˆk
∂θs
+
(
∂Wk
∂vk
∣∣∣∣
τ=τˆ
)
∂2vˆk
∂θq∂θs
(4.32)
where,
∂2vˆ
∂θq∂θs
=
(
ZTWˆZ+Q
)−1 (
ZTWˆ′sZ+Q
′
s
)(
ZTWˆZ+Q
)−1
Q′qvˆ
−
(
ZTWˆZ+Q
)−1 [
Q′′qsvˆ +Q
′
q
∂vˆ
∂θs
]
= −
(
ZTWˆZ+Q
)−1 [(
ZTWˆ′sZ+Q
′
s
) ∂vˆ
∂θq
+Q′′qsvˆ +Q
′
q
∂vˆ
∂θs
]
(4.33)
is a 2n× 1 vector and ∂2vˆk/∂θq∂θs is the first n elements of (4.33) if k = 1 and the second
n elements if k = 2. The ∂2Wk/∂v
2 is found by twice differentiating Wk(βk, vk) = Mk −
NkRkCk(RkNk)
T with respect to vk.
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Now the gradient vector (4.19) and the observed information matrix (4.20) can be cal-
culated using the above quantities. Estimates of θ are updated using the Newton-Raphson
method,
θˆ(i+1) = θˆ(i) +
[−∂2hA
∂θ2
]−1
∂hA
∂θ
∣∣∣∣∣
θ = θˆ(i)
(4.34)
where θˆ(i) is the estimate of θ at the ith iteration.
In summary, the MHLE of β, v and θ are found by using the Newton-Raphson method to
maximize the profile h-likelihood and the adjusted profile h-likelihood. First, the estimates
of β and v are updated with a single Newton-Raphson step on the profile h-likelihood con-
ditional on the current estimate of θ. Then the estimate of θ is updated with a single step of
Netwon-Raphson to maximize the adjusted profile h-likelihood, given the current estimates
of β and v. Continue alternating between (4.9) and (4.34) until convergence is achieved.
Convergence is defined as,
max
{∣∣∣βˆ(i+1) − βˆ(i)∣∣∣ , ∣∣∣θˆ(i+1) − θˆ(i)∣∣∣} < ∆,
where ∆ is a predetermined tolerance limit. After convergence has been achieved, the es-
timated covariance matrix of the parameter estimates is evaluated by taking the inverse of
the observed information matrix (4.15) for the profile h-likelihood.
4.2 ESTIMATING THE CAUSE-SPECIFIC HAZARD UNIVARIATE
FRAILTY MODEL
Assuming a multivariate distribution for the random effects allows for a more general model.
However assuming a univariate distribution requires less computation and is easier to im-
plement. Fitting the cause-specific hazard univariate frailty model is very similar to the
multivariate case. This section outlines the main modifications to the method presented in
the previous section for the multivariate case.
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The h-likelihood assuming a univariate normal distribution is,
h(β, λ0, v, θ) =
∑
ijk
hijk =
∑
ijk
lijk(βk, λ0k; tij, δijk|vi) +
∑
i
li(θ; vi) (4.35)
where,
lijk(βk, λ0k; tij, δijk|vi) = δijk
(
log λ0k(tij) + x
T
ijβk + vi
)− Λ0k(tij) exp (xTijβk + vi)
is the log of the conditional density function for Tij and δijk given Vi = vi and
li(θ; vi) = −1
2
log(2pi)− 1
2
log(θ) +
−v2i
2θ
(4.36)
is the log of the univariate normal density function with mean 0 and variance θ. Since the
random effects no longer depend on the event type Vi represents the effect for any event type
in cluster i and V = (V1, V2, . . . , Vn) is a n-dimensional vector of all the random effects for
every cluster.
The profile h-likelihood is very similar to (4.8),
hp(β, v, θ) =
∑
kr
STXkrβk+S
T
Zkrv−dkr log
( ∑
ij∈Rkr
exp
(
XTijβk+Z
T
ijv
))−dkr+ n∑
i=1
li(θ; vi),(4.37)
where the only change is to the treatment of the random effects. Differentiating (4.37) with
respect to β is identical to (4.12), while the ∂hp/∂v is different,
∂hp
∂v
=
∑
k
ZT (Ek −Mk)− v
θ
. (4.38)
Likewise, there are also changes to the observed information matrix, which is smaller and no
longer block diagonal. Now the observed information of β and v is a (mp + n) × (mp + n)
matrix H given by,
H = H(β, v, θ) =

XTW1X 0 X
TW1Z
0 XTW2X X
TW2Z
ZTW1X Z
TW2X
∑
k Z
TWkZ +Q
 (4.39)
where Wk = Wk(βk, vk) = Mk − NkRkCk(RkNk)T for k = 1, 2 and Q is a n × n diagonal
matrix with ith element −∂2li/∂v2i = 1/θ. Similar modifications are necessary when taking
the first and second derivatives of the adjusted profile h-likelihood.
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When there is only one frailty parameter, it is possible to do higher order approximations;
these higher order approximations are also possible with multiple frailty parameters but
are much more difficult. Estimates of θ can be updated using either the first-order or
second-order Laplace approximation (Lee and Nelder, 2001). For the shared frailty model,
Ha and Lee (2003) recommend the first-order Laplace approximation for models with a
lognormal frailty and the second-order Laplace approximation for models with a gamma
frailty distribution. The first-order Laplace approximation was used in section 4.1 and is
the same as the adjusted profile h-likelihood. The second-order Laplace approximation is
defined by (Lee and Nelder, 2001),
h?A = [hA − trace(S)/24]
∣∣∣∣(β, v) = (βˆ, vˆ) (4.40)
where S is a n× n diagonal matrix where the ith element is,
Si =
[
3
−∂4hp/∂v4i
(−∂2hp/∂v2i )2
− 5(−∂
3hp/∂v
3
i )
2
(−∂2hp/∂v2i )3
]
vi = v˜i
(4.41)
and v˜i is the solution to ∂hp/∂vi = 0 given β. The first derivative of the second-order
approximation is,
∂h?A
∂θ
=
∂hA
∂θ
− 1
24
trace
(
∂S
∂θ
)
(4.42)
and the observed information is,
− ∂
2h?A
∂θ2
= −∂
2hA
∂θ2
− 1
24
trace
(
−∂
2S
∂θ2
)
. (4.43)
For a lognormal frailty distribution a closed form expression for v˜i does not exist. So numer-
ical methods are used to approximate v˜i. For a gamma frailty with mean 1 and variance θ
a closed form solution does exist. Using a second-order Laplace approximation estimates of
θ are updated by,
θ(i+1) = θ(i) +
∂hA/∂θ − 124trace(∂S/∂θ)
−∂2hA/∂θ2 − 124trace(∂2S/∂θ2)
∣∣∣∣
θ = θˆ(i)
. (4.44)
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4.3 ESTIMATING THE SUBHAZARD FRAILTY MODEL
Estimation of the subhazard frailty model is very similar to estimating the cause-specific
hazard univariate frailty model in section 4.2 as well as the shared frailty model. The profile
h-likelihood for the subhazard frailty model is,
hp(β, v, θ) =
∑
r
STXrβ + S
T
Zrv − dr log
∑
r∈Rij
wij(tr) exp
(
XTr β + Z
T
r v
)− dr
+
n∑
i=1
li(θ; vi). (4.45)
where the at risk set Rij and weight function wij(tr) are defined in section 3.5 and li is the
log of a normal density with mean 0 and variance θ.
Notice that (4.45) is similar to the profile h-likelihood for the univariate cause-specific
hazard frailty model (4.37). There are a few differences, first there is a weight function wij(tr);
second the at risk set is different, it includes both individuals who have not experienced an
event and those who experienced a competing event; and third there is only one event type
m = 1 so there is no subscript k.
Given these differences to the profile h-likelihood, the easiest way to modify the method
in section 4.2 to fit the subhazard frailty model is to set m = 1 since only the event of interest
is being modeled. As well as replace the at risk indicator matrix Rk with a weighted at risk
indicator matrix R∗k that contains the weights w as well as the at risk set used for modeling
the subhazard function. Let R∗k = (R
∗
1, R
∗
2, . . . , R
∗
Dk
) be a N ×Dk at risk weighted indicator
matrix where the ijth element in column r for event type k is
I(tij ≥ tkr|δijk 6= 1)× Gˆ(tkr)
Gˆ(min(tkr, tij))
(4.46)
where Gˆ is the Kaplan-Meier estimate of the survival function for the censoring times. Since
the subhazard model assumes a univariate normal distribution it is possible to do higher
order approximations for this model.
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4.4 INFERENCE AND MODEL SELECTION
From Lee et al. (2006), the profile h-likelihood (4.8) can be treated like an ordinary likelihood
for fixed θ. This means that Wald hypothesis tests and confidence intervals can be used for
approximate inference on regression coefficients β and random effects v. Let the partitioned
matrix,
H−1 =
 H11 H12
H21 H22
 (4.47)
be the inverse of the observed information matrix H (4.15) for (βˆ, vˆ) with θ fixed, where
H11 approximates the variance of β (Pawitan, 2001). Then an approximate 100(1 − α)%
confidence interval for β is,
βˆ ± Zα/2(H11)−1/2 (4.48)
where Zα/2 is the α/2 critical value for the standard normal distribution.
The inverse of the observed information matrix for the adjusted profile h-likelihood (4.17)
does a poor job of approximating the variance of the frailty parameter θˆ. PPL methods
have a similar problem and also poorly estimate the standard error of θˆ (McGilchrist, 1993,
Therneau et al., 2003). However, estimating the standard error of θˆ is not very important.
Recall that frailty parameters θ are really variance parameters for the normal distribution
with parameter space θ ≥ 0. Therefore, Wald hypothesis test and confidence intervals cannot
be used to test the hypothesis of no cluster effect θ = 0 because the null hypothesis is on
the boundary of the parameter space.
Nonetheless, a likelihood ratio test can still be used to test the null hypothesis H0 : θ = 0.
Let l1(βˆ, vˆ, θˆ) be the log-likelihood of a competing risks frailty model evaluated at the MHLE
and let l2(βˆ) be the maximum of the log-likelihood for the corresponding submodel with no
random effects. Then the likelihood ratio test statistic is,
ψˆ = −2[l2(βˆ)− l1(βˆ, vˆ, θˆ)]. (4.49)
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Under the null hypothesis this test is on the boundary of the parameter space. Therefore the
asymptotic distribution of the likelihood ratio statistic ψ is no longer chi-squared. Instead,
from Self and Liang (1987) the asymptotic distribution of ψ is a 50:50 mixture distribution
of a χ20 and a χ
2
1 distribution, where χ
2
df denotes a chi-square distribution with df degrees of
freedom. Then the p-value for the likelihood ratio test is 1
2
P (χ21 > ψˆ),
Following Noh et al. (2006), the adjusted profile h-likelihood hA is used for l1 in (4.49).
This approximate likelihood is just a function of θ, where the other parameters β and v as
well as the nuisance parameter λ0 have been removed. Thus it is reasonable to use hA to test
for the frailty effect. The likelihood for the submodel l2 depends on which full model is being
tested. For the subhazard frailty model, l2 is the log-likelihood returned by the Fine and
Gray (1999) model for the hazard function of the subdistribution. Since the cause-specific
hazard frailty model fits all event types jointly, the log-likelihood for this model without
random effects is the complete competing risks log-likelihood (2.33). This can be found
by summing the log-likelihoods returned by fitting a proportional hazards model for each
event type or by modeling the cause-specific hazards jointly (Lunn and McNeil, 1995). A
similar likelihood ratio test was recommended by Katsahian and Boudreau (2011) to test for
clustering effects when using PPL to estimate the subhazard frailty model. There are other
ways to test for clustering. Gray (1992) proposes a Wald test that tests whether all random
effects are 0, H0 : v1 = v2 = . . . = 0.
The univariate and multivariate cause-specific hazard frailty models are non-nested mod-
els; the role of the random effect(s) is different in each model. To select which model is more
appropriate Akaike’s information criterion (AIC) can be used (Ha et al., 2007). Define the
AIC criteria as,
AIC = −2hA(θˆ) + 2s, (4.50)
where hA(θˆ) is the maximum adjusted profile h-likelihood and s is the number of variance
components in Σ; s is not the total number of parameters. The model with the smaller AIC
indicates a better fitting model. The term 2s acts like a penalty increasing the AIC for using
a more complex correlation structure that will most likely increase hA and decrease the AIC.
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Using the AIC, a more complex model with more parameters will only be selected if there
is a marked improvement in the model fit.
The AIC criteria can also be used to select which correlation structure for Σ gives the best
fit when using the multivariate model, as well as choose between a model with random effects
and without random effects.The AIC for a model without random effects is simply -2 times
the log-likelihood from the corresponding competing risks model. There are no variance
components so s = 0. However it may make more sense to fit the simpler univariate frailty
model and test the cluster effect using (4.49). This AIC criteria cannot be used to select
fixed effects β since they have been eliminated from hA; the adjusted profile h-likelihood is
just a function of the frailty parameters θ.
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5.0 SIMULATION
Simulations by Ha et al. (2001) and Ha and Lee (2003) have demonstrated that h-likelihood
performs well under a variety of scenarios when estimating the shared frailty model. More-
over simulations results by Ha et al. (2011) have also shown that h-likelihood performs
well assuming a bivariate frailty distribution when fitting the shared frailty model with two
random effects. All of the previously mentioned simulations have also shown that misspecifi-
cation of the frailty distribution has a minimal effect on the estimated covariates when using
h-likelihood.
In this chapter simulation studies are performed to evaluate the performance of the h-
likelihood estimation method when fitting competing risks frailty models. First, section 5.1
demonstrates the performance of using h-likelihood to fit the cause-specific hazard frailty
model assuming both a univariate and bivariate normal distribution. This section also uses
simulation to evaluate the accuracy of the AIC criteria for selecting the most appropriate
covariance structure for the bivariate frailty distribution from a collection of possible covari-
ance structures. Then section 5.2 compares h-likelihood and the PPL method proposed by
Katsahian and Boudreau (2011) for fitting the subhazard frailty model. Simulation results
by Katsahian and Boudreau (2011) demonstrate that PPL does well when the cluster size
is large. Therefore the purpose of this section is to compare h-likelihood and PPL for cases
when the cluster size is small. Additional simulations examine the consequences of ignoring
clustering when analyzing competing risks data. Each section includes details on how to
simulate competing risks data in general. Simulating competing risks data is not as simple
as using the probability integral transformation, where data is generated from a distribution
function F (x) by solving the equation F (x) = u for x where u is a random standard uniform
number.
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The performance of the estimators θˆ for estimating the parameters θ are evaluated and
compared using the relative bias or percent bias,
%Bias(θˆ) =
E(θˆ)− θ
θ
× 100 (5.1)
and the mean square error,
MSE(θˆ) = Var(θˆ) + (E(θˆ)− θ)2, (5.2)
as well as the coverage probability for a confidence level of 95%, the proportion of samples
whose 95% confidence interval contains the true value of the parameter.
5.1 CAUSE-SPECIFIC HAZARD FRAILTY MODEL
5.1.1 Data Generation
Event times for the cause-specific hazard frailty model are generated using a procedure
similar to the one given by Beyersmann et al. (2009). This approach uses the cause-specific
hazard functions rather than assume a latent failure time model. A latent failure time model
(Pintilie, 2006) assumes that there is an unobserved event time for each event type. Of these
hypothetical event times, only the minimum event time is observed. Simulating competing
risks event times from a latent failure time model by assuming some multivariate distribution
for all of the event times and selecting the minimum event time is valid. However, this method
does not reflect how competing risks data is actually analyzed. It is well known that the
dependence structure between latent failure times cannot be identified from the observed
data where only one of the competing events is recorded for each individual (Tsiatis, 1975).
So, rather than simulating data using a method that requires specifying an unidentifiable
dependence structure, the following procedure only relies on identifiable quantities by using
the cause-specific hazard functions.
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Suppose there are two event types, Type I and Type II. Then the data generation pro-
cedure is based on the following observation; given that an individual has an event at time
T = t the probability that the individual fails from the Type I event is,
P (δ1 = 1|T ∈ ∆t, T ≥ t) = P (T ∈ ∆t, δ1 = 1|T ≥ t)
P (t ∈ ∆t|T ≥ t)
=
λ1(t)
λ1(t) + λ2(t)
, (5.3)
where ∆t denotes both the length of the infinitesimal interval [t, t+∆t) as well as the interval
itself; δ1 is the Type I event indicator and λ1(t) and λ2(t) are the cause-specific hazards for
the Type I and Type II event, respectively (section 2.2).
The general data generation procedure is as follows,
1. Generate appropriate covariate values X for each observation.
2. Generate n random effects v, one per cluster, from an assumed distribution.
3. Specify the cause-specific hazards λ1(t|X, v) and λ2(t|X, v) conditional on the covariates
and random effect.
4. Simulate survival times T from the overall hazard function λ1(t|X, v) + λ2(t|X, v) using
the probability integral transformation (Bender et al., 2005).
5. Determine which event type is associated with the simulated time T by running a
Bernoulli experiment which selects a Type I event with probability,
λ1(t|X, v)
λ1(t|X, v) + λ2(t|X, v) .
6. Generate independent non-informative censoring times C.
7. Select the observed event time as the minimum of T and C and create a variable to
indicate the event type and censoring status.
If there are more than two event types replace the Bernoulli experiment in step 5 with a
multinomial experiment.
Using this data simulation method, data is generated for the two non-nested cause-
specific hazard frailty models from section 3.4. The first is (3.35) which assumes a univariate
normal distribution. The second is (3.36) which includes a random effect for each event type
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and assumes a bivariate normal distribution. The simulation scheme is the same for both
model. The only difference is the distribution of the random effects.
Let there be two event types, Type I and Type II as well as independent censoring.
Samples sizes of N = 100 and N = 200 are considered where (n, ni) = (50, 2), (50, 4) and
(100, 2). Data were generated with two covariates (Xij1, Xij2), where Xij1 follows a standard
normal distribution and Xij2 is a Bernoulli random variable with probability 0.5. For the
univariate case the random effects Vi are generated from a N(0, θ) distribution with θ = 1.
For the bivariate case the random effects are bivariate normal,
 vi1
vi2
 ∼ N
 0
0
 ,
 σ11 σ12
σ21 σ22
 (5.4)
where the true values of the variance components are,
 σ11 σ12
σ21 σ22
 =
 1 0.5
0.5 1
 (5.5)
and the correlation between the two event types is ρ = 0.5; θ = (σ11, σ22, σ12) = (1, 1, 0.5).
For the bivariate case, the conditional cause-specific hazard rates for each event type are (for
the univariate case replace vi1 and vi2 with vi),
λij1(t|xij, vi1) = 0.5 exp(0.6xij1 − 0.4xij2 + vi1)
λij2(t|xij, vi2) = 2 exp(−0.3xij1 + 0.7xij2 + vi2)
That is, β1 = (β11, β12) = (0.6,−0.4) and β2 = (β21, β22) = (−0.3, 0.7). Under this scenario,
approximately 65% of the events are Type I and 35% are Type II when there is no censoring.
The baseline hazards were selected to control the proportion of each event type. Censoring
times are generated from a Uniform(0, τ) distribution where the value of τ is empirically
selected to achieve the approximate right censoring rate, 0% and 30%. For each scenario,
500 datasets were generated.
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5.1.2 Results
The simulation results for the univariate case where (3.35) is the true model are give in Table
5.1. This table as well as subsequent tables report the mean and standard deviation of the
estimates from the 500 iterations as well as the average of the estimated standard errors for
the regression coefficients. The last three columns give the percent bias, mean square error
and coverage probability, respectively.
Whether there is no censoring or 30% censoring, h-likelihood returns estimates close to
the true value of the parameters for the Type I effects, β11 and β12. There is some difficulty
estimating the coefficients for the Type II event when the sample size is small. This was
expected since there are fewer Type II events than Type I events. Estimation of β21 and β22
is improved with larger sample sizes; there is a greater improvement when the cluster size
increases. Larger cluster sizes rather than more clusters also give better estimates of the
frailty parameter θ when there is censoring. Increasing the censoring rate does not seem to
have a major impact on the performance of the estimates.
The estimated standard errors of the regression coefficients tend to underestimate the
empirical standard deviation for most of the scenarios, but are pretty close. Similar results
were shown by Ha et al. (2001) and Ha and Lee (2003) for the shared frailty model using h-
likelihood. Ripatti and Palmgren (2000) also reported underestimated standard errors with
the PPL estimator for the shared frailty model. This results in coverage probabilities being
less than 95%. Nonetheless all of the coverage probabilities in this simulation still remain
in the 92%-96% range. Larger cluster sizes tended to have larger coverage probabilities and
more accurate estimated standard errors. As expected, the mean square error decreases for
larger samples. There is a larger decrease in MSE when the cluster size is double compared
to when the number of clusters is doubled. Ha and Lee (2003) also demonstrated that
increasing the cluster size rather than the number of clusters had a bigger impact on reducing
the variance and bias of the estimator for the shared frailty model.
With 0% censoring, 97% of the samples converge when n = 50 and ni = 2 and 1 sample
failed to converge when n = 100 and ni = 2. These samples were not included in Table 5.1.
For the remaining scenarios, all of the samples converged.
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Table 5.1: Simulation results, cause-specific hazard frailty model - univariate case
Censoring Sample Size Parameter Mean SD SE %Bias MSE CP
0% n = 50, ni = 2 β11 0.614 0.175 0.172 2.3 0.031 95.7
β12 -0.412 0.343 0.319 3.1 0.118 94.3
β21 -0.340 0.246 0.231 13.4 0.062 93.3
β22 0.758 0.480 0.443 8.3 0.234 93.3
θ 1.016 0.539 1.6 0.290
n = 50, ni = 4 β11 0.601 0.112 0.111 0.1 0.012 95.6
β12 -0.386 0.202 0.206 -3.6 0.041 96.2
β21 -0.299 0.157 0.150 -0.5 0.024 94.2
β22 0.706 0.279 0.289 0.8 0.078 96.6
θ 1.018 0.345 1.8 0.120
n = 100, ni = 2 β11 0.593 0.120 0.118 -1.2 0.014 94.0
β12 -0.399 0.233 0.220 -0.1 0.054 94.2
β21 -0.311 0.166 0.157 3.5 0.028 94.8
β22 0.722 0.292 0.301 3.2 0.086 95.2
θ 0.940 0.348 -6.0 0.125
30% n = 50, ni = 2 β11 0.617 0.212 0.196 2.9 0.045 94.4
β12 -0.404 0.385 0.368 0.9 0.148 94.8
β21 -0.329 0.279 0.264 9.5 0.079 94.6
β22 -0.712 0.565 0.522 1.8 0.319 94.4
θ 1.071 0.645 7.1 0.421
n = 50, ni = 4 β11 0.613 0.137 0.129 2.2 0.019 92.2
β12 -0.405 0.231 0.240 1.2 0.053 95.8
β21 -0.299 0.166 0.176 -0.1 0.027 96.0
β22 -0.692 0.355 0.345 -1.1 0.126 96.0
θ 1.010 0.388 1.0 0.151
n = 100, ni = 2 β11 0.598 0.141 0.134 -0.3 0.020 91.6
β12 -0.413 0.259 0.253 3.3 0.067 95.6
β21 -0.317 0.185 0.182 5.5 0.035 94.6
β22 0.731 0.381 0.360 4.5 0.146 94.6
θ 0.921 0.372 -7.9 0.145
Mean and SD are the mean and standard deviation of the estimates from the 500
iterations. SE is the mean of the estimated standard errors. %Bias denotes the
percent bias, MSE is the mean square error and CP is the coverage probability.
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Next the simulation results for the bivariate case where the true model is (3.36) are
presented in Tables 5.3 and 5.4; Table 5.3 gives the results for the estimated regression
coefficients and Table 5.4 gives the results for the estimated variance components.
In Table 5.3 the results for the regression coefficients are similar to the univariate case
in Table 5.1. Estimators of the Type I effects (β11, β12) perform well with no censoring and
30% censoring. As the sample size increases the estimators become less bias. With 30%
censoring there is a little bit of difficulty estimating the Type II effects, however for larger
sample sizes these estimators become less bias when censoring is present.
Like Table 5.1, the estimated standard errors of the regression coefficients tend to un-
derestimate the empirical standard deviation. As a result most of the coverage probabilities
are less than 95%. Increasing the sample sizes gives more accurate estimates of the standard
errors. However, the estimated standard errors for larger samples still tend to underestimate
the empirical standard deviation and have coverage probabilities less than 95%. Increasing
the sample size also reduces the standard deviation of the estimates and the MSE, as ex-
pected. Unlike in Table 5.1, there is no clear advantage between increasing the number of
clusters n or the cluster size ni.
Estimates of the variance components in Table 5.4 are more biased compared to the
estimates of the corresponding regression coefficients presented in Table 5.3, in particular,
the estimated variance for the Type II random effects σ22. This was also expected since there
were few Type II events in this simulation. Increasing the number of clusters rather than the
cluster size improves the estimation of this parameter. Increasing the sample size also reduces
the standard deviation of all the estimators as well as the MSE. For the larger sample cases,
the estimates of the variance components are not as accurate as the estimated regression
coefficients for the same sample sizes. Further increasing the sample size to N = 400 with
n = 100 and ni = 4 reduces the bias and variance of the variance component estimators as
well as the estimated regression coefficients (results not shown).
A case was also considered were the correlation between the random effects was negative
and the random effects were heterogeneous (σ11 = 0.5, σ22 = 1.5, ρ = −0.5); for a sample
size of N = 200 where n = 50, ni = 4 with 30% censoring. In this case, the percent bias and
coverage probability for the regression coefficients were similar to the corresponding results
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Table 5.2: Percent bias and coverage probabilities from fitting the cause-specific hazard
model and subhazard model ignoring the random effect Vi; Vi ∼ N(0, θ).
Cause-Specific Hazard Model Subhazard Model
θ Parameter %Bias CP %Bias CP
0.5 β11 -9.3 91.9 -12.6 88.2
β12 -3.6 96.6 -13.0 94.2
1 β11 -16.6 83.2 -21.4 76.8
β12 -8.1 92.9 -20.6 92.7
2 β11 -23.8 72.7 -34.0 51.4
β12 -10.0 93.3 -38.2 87.9
%Bias denotes the percent bias and CP is the coverage probability.
in Table 5.3. The estimates of the variance components were also similar to results in Table
5.4 (results not shown). Demonstrating that h-likelihood methods work under a variety of
conditions, not just nicely structured scenarios.
For 0% censoring, 98% of the samples converged when n = 50 and ni = 2; 99% converged
when n = 50 and ni = 4. For all of the remaining scenarios all of the samples converged.
Samples that failed to converge were not included in Tables 5.3 or 5.4.
Ignoring the random effects and fitting the cause-specific hazard model using the pro-
portional hazards model where all competing events are treated as censored observations
results in underestimation of the true values. The bias of these estimates increases and the
coverage probability drops well below the nominal 95% confidence level as the variance of the
random effects increases (Table 5.2). Similar results were seen for the shared frailty model,
see Henderson and Oman (1999) and the references therein.
Overall, h-likelihood provides reasonably close estimates of the true parameters as well
as reasonable 95% coverage probabilities for the cause-specific hazard frailty model assuming
either a univariate or bivariate normal distribution for the random effects. The results of
these simulations indicate that the estimators will perform fairly well with small samples
sizes and improve in efficiency and reduce bias as the sample size increases.
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Table 5.3: Simulation results for β, cause-specific hazard frailty model - bivariate case
Censoring Sample Size Parameter Mean SD SE %Bias MSE CP
0% n = 50, ni = 2 β11 0.616 0.188 0.177 -2.7 0.036 95.1
β12 -0.391 0.342 0.331 2.2 0.117 94.7
β21 -0.307 0.248 0.231 -2.2 0.061 94.5
β22 0.701 0.457 0.443 -0.1 0.208 96.3
n = 50, ni = 4 β11 0.602 0.117 0.115 0.3 0.014 93.0
β12 -0.418 0.219 0.214 4.6 0.048 93.4
β21 -0.297 0.156 0.152 -0.9 0.024 94.6
β22 0.709 0.304 0.292 1.3 0.093 94.8
n = 100, ni = 2 β11 0.585 0.128 0.122 -2.5 0.017 92.8
β12 -0.391 0.219 0.228 -2.3 0.048 96.4
β21 -0.302 0.167 0.157 0.6 0.028 93.4
β22 0.698 0.306 0.303 -0.2 0.094 95.6
30% n = 50, ni = 2 β11 0.620 0.222 0.199 3.3 0.050 93.0
β12 -0.428 0.413 0.377 7.0 0.171 92.2
β21 -0.324 0.297 0.271 8.0 0.089 93.0
β22 0.780 0.560 0.534 11.5 0.320 96.1
n = 50, ni = 4 β11 0.597 0.139 0.130 -0.5 0.019 94.2
β12 -0.406 0.260 0.247 1.5 0.067 93.6
β21 -0.295 0.188 0.176 -1.6 0.035 93.4
β22 0.732 0.364 0.348 4.6 0.133 93.6
n = 100, ni = 2 β11 0.586 0.140 0.135 -2.4 0.020 96.2
β12 -0.391 0.263 0.257 -2.1 0.069 94.4
β21 -0.301 0.187 0.180 0.4 0.035 94.8
β22 0.668 0.351 0.353 -4.5 0.124 95.2
Mean and SD are the mean and standard deviation of the estimates from the 500
iterations. SE is the mean of the estimated standard errors. %Bias denotes the
percent bias, MSE is the mean square error and CP is the coverage probability.
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Table 5.4: Simulation results for θ, cause-specific hazard frailty model - bivariate case
Censoring Sample Size Parameter Mean SD %Bias MSE
0% n = 50, ni = 2 σ11 1.059 0.565 -5.9 0.322
σ22 1.262 0.947 -26.2 0.966
σ12 0.478 0.577 4.4 0.333
ρ 0.421 0.389 -15.8 0.158
n = 50, ni = 4 σ11 0.999 0.360 -0.1 0.130
σ22 1.105 0.535 10.5 0.297
σ12 0.501 0.328 0.3 0.108
ρ 0.487 0.250 -2.6 0.063
n = 100, ni = 2 σ11 0.969 0.390 -3.1 0.153
σ22 1.001 0.458 0.1 0.210
σ12 0.440 0.339 -12.0 0.118
ρ 0.446 0.276 -10.8 0.079
30% n = 50, ni = 2 σ11 1.179 0.803 17.9 0.676
σ22 1.491 1.625 49.1 2.882
σ12 0.449 0.750 -10.3 0.566
ρ 0.352 0.458 -29.6 0.232
n = 50, ni = 4 σ11 1.013 0.429 1.3 0.184
σ22 1.107 0.550 10.7 0.314
σ12 0.503 0.365 0.5 0.133
ρ 0.479 0.265 -4.2 0.071
n = 100, ni = 2 σ11 0.947 0.422 -5.3 0.181
σ22 1.042 0.527 4.2 0.146
σ12 0.478 0.381 -4.4 0.279
ρ 0.475 0.279 -5.0 0.078
Mean and SD are the mean and standard deviation of the estimates from the 500
iterations. %Bias denotes the percent bias and MSE is the mean square error.
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Table 5.5: Percent of samples selected using AIC for each model versus the true model;
diagonal elements give the percentage of samples that were correctly selected.
AIC Selected Model
True Model M1 M2 M3
M1 93.4 2.2 4.4
M2 5.0 80.8 14.2
M3 38.8 42.4 18.8
M1 = Cause-specific hazard frailty model with one random effect
M2 = Cause-specific hazard frailty model with two independent random effects
M3 = Cause-specific hazard frailty model with two correlated random effects
Table 5.5 gives the results of a simulation study investigating the use of AIC to select
the most appropriate model. A sample of size N = 200 with n = 50 and ni = 4 and 30%
censoring were used. Baseline hazard rates and covariates are the same as the previous
simulations. Three structures for the random effects were used,
(M1) Cause-specific hazard frailty model with one random effect (3.35) that follows a standard
normal distribution,
vi ∼ N(0, 1)
(M2) Cause-specific hazard frailty model with two independent random effects (3.36) that
follows a bivariate normal distribution, vi1
vi2
 ∼ N
 0
0
 ,
 1 0
0 1

(M3) Cause-specific hazard frailty model with two correlated random effects (3.36) that follows
a bivariate normal distribution, vi1
vi2
 ∼ N
 0
0
 ,
 1 0.5
0.5 1

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Notice that (M1) only has one variance component, (M2) has two variance component and
(M3) has three variance components.
From Table 5.5, AIC does a good job selecting the correct model when the true model is
(M1) or (M2); 93.4% of samples are correctly selected when (M1) is the true model and 80.8%
of samples when (M2) is the true model. However there is difficulty selecting the correct
model when the true model is (M3), only 18.8% of the samples were correctly selected.
This is most likely because the AIC for (M3) has a larger penalty term since three variance
components are being estimated. The average difference between (M2) and (M3) is just 1.16
this difference is most likely due to the larger penalty term for (M3) that is the result of
estimating the extra covariance parameter. The average AIC is smallest for (M3), 1230.7
and larger for (M2), 1231.9.
For larger cluster sizes AIC has an easier time selecting the correct model (Ha et al.,
2007). Increasing the sample size to n = 50 and ni = 7 results in AIC correctly selecting
(M3) 69.8% of the time as the better fitting model when this is in fact the true model. Under
this scenario the incorrect models had some trouble converging: for (M1) 80% converged and
for (M2) 97% converged; suggesting that convergence trouble may indicate that the model
is not complex enough to support the data.
Recall from section 3.4, that for (M1) the correlation between event times cannot be
negative. If the true model is (M3) but now with negative correlation ρ = −0.5 then (M1)
is only selected 0.8% of the time while (M2) is selected 48% and (M3) is selected 51% of the
time. Thus there is still trouble distinguishing between (M2) and (M3), but the model that
does not allow negative association is barely selected at all.
5.2 SUBHAZARD FRAILTY MODEL
5.2.1 Data Generation
Since the effect of a covariate on the cause-specific hazard function can be very different
from the effect of the same covariate on the subhazard function (Fine and Gray, 1999, Gray,
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1988), a different technique needs to be used to generate event times for the subhazard
frailty model. Suppose there are two event types, Type I and II where Type I is the event
of interest. Following Fine and Gray (1999), think of the subhazard function for the Type I
event γ1(t) as the hazard function for the improper random variable,
T ∗ = I(δ1 = 1)× T + I(δ1 = 0))×∞ (5.6)
where δ1 is the event indicator for Type I events.
Let p = P (δ1 = 1) = 1− P (δ1 = 0) such that for all t ∈ [0,∞), P (T ∗ < t|δ1 = 1) = F (t)
and P (T ∗ < t|δ1 = 0) = 0, where F (t) is a proper distribution function for T . Then the
distribution function of T ∗ is a mixture of F (t) and a degenerate random variable with a
point mass of 1− p at t =∞. For t ∈ [0,∞) the distribution function of T ∗ is,
P (T ∗ < t) = pP (T < t|δ1 = 1) + (1− p)P (T < t|δ1 = 0)
= pF (t)
= F1(t)
where F1(t) is a subdistribution function for the Type I event. Similarly, when t =∞,
P (T ∗ =∞) = pP (T =∞|δ1 = 1) + (1− p)P (T =∞|δ1 = 0)
= p(1− F (∞)) + (1− p)
= 1− p
The distribution function of T ∗ can be written as,
FT ∗(t) = P (T
∗ < t) =
 F1(t) if t <∞1− p if t =∞ (5.7)
The conditional subhazard function for a Type I event for the jth observation of cluster
i is,
γij1(t|Xij, vi) = γ01(t) exp(XTijβ1 + vi) (5.8)
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It follows that the corresponding subdistribution function for Type I failures conditional on
the covariates Xij and random effects vi is,
F1(t|Xij, vi) = 1− exp
(
−
∫ t
0
γ01(u) exp(X
T
ijβ1 + vi) du
)
= 1− [1− pF (t)]exp(XTijβ1+vi) . (5.9)
The probability of a Type I event δij1 = 1 for observation ij given Xij and vi is,
P (δij1 = 1|Xij, vi) = lim
t→∞
F1(t|Xij, vi) = 1− (1− p)exp(XTijβ1+vi). (5.10)
As a result, the proper distribution function of Tij conditional on a Type I cause of failure
as well as Xij and vi is,
F (t|Xij, vi, δij1 = 1) = 1− [1− pF (t)]
exp(XTijβ1+vi)
1− (1− p)exp(XTijβ1+vi)
. (5.11)
Type I event times are then generated from the above distribution function using the
probability integral transformation, conditional on simulated values of the covariates Xij
and random effects vi. Following Fine and Gray (1999) a specific form of the subhaz-
ard function for Type II events is not specified. Recall, the estimation procedure in sec-
tion 4.3 only estimates the regression parameters for the event of interest, in this case
Type I events. Thus the subdistribution for Type II events is simply obtained by tak-
ing, P (δij2 = 1|Xij, vi) = 1 − P (δij1 = 1|Xij, vi) and using an exponential distribution with
rate exp(XTijβ2 +vi) for F (t|Xij, vi, δij2 = 1). In other words, the proper distribution function
of Tij conditional on a Type II cause of failure as well as Xij and vi is,
F (t|Xij, vi, δij2 = 1) = 1− exp
(− exp(XTijβ2 + vi)t) . (5.12)
Like before, Type II events are simulated from the above distribution using the probability
integral transformation.
Lastly, independent censoring times are simulated. Then the observed event time is the
minimum of the event times and the censoring times and an indicator variable is used to
denote the event type and censoring status.
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Beyersmann et al. (2009) provides an alternative strategy for simulating subhazard data
based on the cause-specific hazard functions. Compared to the method given by Fine and
Gray (1999), Beyersmann et al. (2009) approach can take more computing time.
Following Katsahian and Boudreau (2011), assume the proper distribution of T is a unit
exponential distribution, F (t) = 1 − e−t. Data were generated with two covariates Xij =
(Xij1, Xij2), where Xij1 follows a standard normal distribution and Xij2 is a Bernoulli random
variable with probability 0.5. The random effects Vi are generated from a N(0, θ) distribution
with θ = {0.5, 1, 2}. Sample sizes were N = 100 and N = 200 with (n, ni) = (50, 2) and
(50, 4). Only small cluster sizes were considered because the purpose of this simulation is to
compare h-likelihood and PPL when the cluster size is small. The proportion p in (5.11) and
(5.12) is the the proportion of Type I events when there is no random effect and the covariates
are all 0, p = P (δij1 = 1|Xij1 = 0, Xij2 = 0, vi = 0). Two values of p are considered 0.3 and
0.7. The true regression coefficients for the Type I events are β1 = (β11, β12) = (0.6,−0.4).
and regression coefficients for the Type II event are, β2 = (β21, β22) = (−0.3, 0.7). Censoring
times are generated from a Uniform(0, τ) distribution where the value of τ is empirically
selected to achieve the approximate right censoring rate, 0% and 30%. For each scenario 500
datasets were generated.
In this simulation the PPL method is also used to fit the subhazard frailty model. The
PPL method was performed following Katsahian and Boudreau (2011) using the R func-
tion coxme in the coxme package (R Development Core Team, 2010, Therneau, 2009) with
counting process notation and time dependent weights like in section 4.3.
5.2.2 Results
The simulation results for the case with 0% censoring are in Table 5.6. With no censoring
h-likelihood gives more accurate estimates of the regression coefficients and the frailty pa-
rameter for large values of θ, when the population is more heterogeneous. However, when
θ = 0.5 PPL gives more accurate estimates. Estimates for both methods are slightly more
bias and slightly more variable when p = 0.3 compared to when p = 0.7. Overall, the
standard deviation of the estimates are roughly the same for both methods.
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Table 5.6: Simulation results, subhazard frailty model with 0% censoring
Sample H-Likelihood PPL
Size p θ Mean SD %Bias MSE Mean SD %Bias MSE
n = 50 0.7 0.5 β1 0.613 0.183 2.2 0.034 0.604 0.181 0.7 0.033
ni = 2 β2 -0.401 0.306 0.4 0.093 -0.396 0.303 -1.0 0.092
θ 0.551 0.408 10.3 0.169 0.485 0.390 -2.9 0.152
1 β1 0.603 0.185 0.5 0.034 0.593 0.182 -1.1 0.033
β2 -0.381 0.325 -4.7 0.106 -0.375 0.319 -6.2 0.103
θ 0.985 0.639 -1.5 0.409 0.887 0.589 -11.3 0.360
2 β1 0.589 0.205 -1.9 0.042 0.575 0.201 -4.1 0.041
β2 -0.399 0.370 -0.1 0.137 -0.391 0.362 -2.2 0.131
θ 1.995 1.095 -0.3 1.199 1.792 0.984 -10.4 1.013
0.3 0.5 β1 0.620 0.229 3.3 0.053 0.612 0.226 1.9 0.051
β2 -0.399 0.433 -0.1 0.187 -0.395 0.428 -1.2 0.183
θ 0.592 0.579 18.4 0.344 0.491 0.542 -1.9 0.294
1 β1 0.576 0.231 -3.9 0.054 0.567 0.228 -5.5 0.053
β2 -0.413 0.443 3.3 0.197 -0.407 0.435 1.7 0.190
θ 0.986 0.710 -1.4 0.504 0.859 0.643 -15.1 0.436
2 β1 0.584 0.236 -2.6 0.056 0.571 0.231 -4.8 0.054
β2 -0.392 0.451 -2.1 0.203 -0.382 0.439 -4.4 0.193
θ 1.923 1.277 -3.9 1.637 1.682 1.121 -15.9 1.358
Mean and SD are the mean and standard deviation of the estimates from the 500
iterations. %Bias denotes the percent bias and MSE is the mean square error.
The results for the 30% censoring case are in Table 5.7. Like Table 5.6, h-likelihood gives
less bias results when θ = 1, 2 while PPL gives more accurate estimates for θ = 0.5. The
case where p = 0.3 and 30% censoring for a sample of size n = 50 and ni = 2, is not included
because this sample size was too small to guarantee reliable meaningful results. The biggest
difference between the two methods is the estimation of θ. H-likelihood gives more accurate
estimates of θ compared to PPL. Especially when there is not a lot of information, 30%
censoring and p = 0.3 (Figure 5.1). This is most likely the result of h-likelihood using a higher
order approximation to estimate θ. It is important to get an accurate estimate of the frailty
parameter θ because underestimating the frailty parameter will result in underestimating
the regression coefficients β as well (Henderson and Oman, 1999).
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Figure 5.1: Percent bias of θˆ for h-likelihood and PPL with 30% censoring and n = 50,
ni = 4
Results from Katsahian and Boudreau (2011) showed that estimates of θ overestimate the
true value of the parameter. The results in Table 5.6 and 5.7 have θ being underestimated.
The difference is probably due to the sample sizes. Katsahian and Boudreau (2011) used
very large clusters and few clusters, while this simulation study uses small cluster sizes, but a
large number of clusters. The one case Katsahian and Boudreau (2011) ran with 50 clusters
of size 20 did underestimate the true value of θ.
Ignoring the frailty effect and fitting the subhazard model from Fine and Gray (1999)
results in very biased estimates and low coverage probabilities (Table 5.2).
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Table 5.7: Simulation results, subhazard frailty model with 30% censoring
Sample H-Likelihood PPL
Size p θ Mean SD %Bias MSE Mean SD %Bias MSE
n = 50 0.7 0.5 β1 0.601 0.198 0.1 0.592 0.592 0.198 -1.4 0.039
ni = 2 β2 -0.406 0.372 1.4 0.138 -0.399 0.370 -0.02 0.137
θ 0.571 0.578 14.2 0.339 0.487 0.613 -2.5 0.375
1 β1 0.588 0.201 -1.9 0.041 0.579 0.199 -3.5 0.040
β2 -0.378 0.358 -5.5 0.129 -0.372 0.352 -7.0 0.125
θ 0.909 0.619 -9.1 0.391 0.796 0.397 -20.4 0.370
2 β1 0.587 0.219 -2.2 0.048 0.573 0.214 -4.5 0.046
β2 -0.387 0.407 -3.3 0.166 -0.379 0.397 -5.3 0.158
θ 1.825 1.105 -8.8 1.252 1.617 0.978 -19.1 1.103
n = 50 0.7 0.5 β1 0.607 0.135 1.1 0.018 0.604 0.134 0.7 0.018
ni = 4 β2 -0.415 0.249 3.8 0.062 -0.413 0.248 3.3 0.061
θ 0.478 0.276 -4.4 0.076 0.453 0.270 -9.5 0.075
1 β1 0.602 0.131 0.3 0.017 0.599 0.130 -0.2 0.017
β2 -0.389 0.248 -2.6 0.062 -0.387 0.247 -3.1 0.061
θ 0.972 0.401 -2.7 0.161 0.932 0.384 -6.8 0.152
2 β1 0.596 0.130 -0.6 0.017 0.593 0.129 -1.2 0.017
β2 -0.417 0.239 4.2 0.058 -0.414 0.238 3.5 0.057
θ 1.948 0.636 -2.6 0.407 1.880 0.653 -6.0 0.441
0.3 0.5 β1 0.594 0.175 -1.0 0.031 0.591 0.174 -1.4 0.030
β2 -0.418 0.341 4.5 0.117 -0.416 0.340 4.0 0.116
θ 0.474 0.356 -5.2 0.127 0.431 0.352 -13.7 0.128
1 β1 0.596 0.191 -0.6 0.036 0.593 0.190 -1.2 0.036
β2 -0.354 0.340 -11.3 0.118 -0.353 0.339 -11.7 0.117
θ 0.943 0.510 5.7 0.264 0.890 0.489 -11.0 0.251
2 β1 0.617 0.158 2.9 0.025 0.613 0.157 2.2 0.025
β2 -0.414 0.312 3.5 0.098 -0.411 0.310 2.7 0.097
θ 1.92 0.840 -3.8 0.711 1.842 0.828 -7.9 0.711
Mean and SD are the mean and standard deviation of the estimates from the 500
iterations. %Bias denotes the percent bias and MSE is the mean square error.
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6.0 APPLICATION
The B-14 phase III breast cancer clinical trial conducted by the National Surgical Adjuvant
Breast and Bowel Project (NSABP) was a randomized double-blind multi-center trial com-
paring tamoxifen to placebo following surgery in patients who had negative axillary lymph
nodes and estrogen receptor positive breast cancer (ER-positive). The tumors of women who
are ER-positive have receptors that bind to the hormone estrogen and rely on this hormone
to grow. Tamoxifen binds to estrogen receptors and inhibits the growth of the tumor by
blocking estrogen from binding to the tumor.
In the B-14 trial, the placebo arm had 1413 eligible patients with follow-up and the
tamoxifen arm had 1404 eligible patients with follow-up information. The study concluded
that patients treated with tamoxifen had a significantly better outcome than those treated
with placebo (Fisher et al., 1989, 1996). The study also observed a significant reduction of
new primary cancers in the contralateral (opposite) breast for women receiving tamoxifen.
This result of the B-14 study led to the P-1 Breast Cancer Prevention Trial (BCPT) where
women who do not have breast cancer but are at an increased risk were randomly assigned
to tamoxifen or placebo for 5 years. This study also demonstrated the benefits of tamoxifen,
concluding that tamoxifen led to a 49% reduction in the risk of invasive breast cancer (Fisher
et al., 1998).
In this chapter two separate analysis of the B-14 data are presented to illustrate h-
likelihood procedures in real applications. First in section 6.1 the cause-specific hazard
frailty model is used to estimate the effect of tamoxifen on different types of failures where
some subjects experienced multiple events and competing risks are present. Next section 6.2
looks at the effect of tamoxifen on local or regional recurrence adjusting for possible center
effects using the subhazard frailty model. For both analyses, p-values less than 0.05 are
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considered statistically significant. Moreover all descriptives and inference for the random
effects were done on the normal scale and not the lognormal scale.
6.1 REPEATED EVENTS WITH MULTIPLE TYPES OF EVENTS AND A
TERMINAL EVENT
This analysis will use a high risk subset of patients from the B-14 study, those subject with
a tumor size greater than 2.5 centimeters. In this subset there are 731 women (371 placebo
and 360 tamoxifen) who are eligible with follow-up. The median age for women on either
placebo or treatment was 55 years. The assigned therapy was administered for five years
since randomization or until the first treatment failure, whichever came first. Multiple types
of treatment failure are possible: local, regional, or distant recurrence of the original cancer
as well as a new second primary cancer or death. Patients were followed after discontinuing
therapy. Thus more than one failure type may be experienced and recorded for each subject.
Since these repeated events are occurring on the same subject and each subject has a unique
medical history, family history, etc it is very reasonable that the multiple event times for a
patient are correlated.
The objective of this analysis is to assess the effect of treatment on local or regional
recurrence and second primary cancer in the contralateral breast as well as to get an idea
of the association between these two types of events. For the purpose of this analysis the
types of failures will be divided into three event types. The first type (Type I) is a local
or regional recurrence, the second type (Type II) is a new second primary cancer in the
contralateral breast and the third type (Type III) is a distant recurrence, other new second
primary cancer or death.
The occurrence of a Type III event before a Type I or Type II event can substantially
change the effect of the treatment solely preventing a Type I or Type II event, because
additional therapies in addition to tamoxifen may be administered. Therefore, the Type III
events are competing with the Type I and Type II events; the Type I and Type II events
are not competing with each other nor are they competing with the Type III event.
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Table 6.1: Event type by treatment group for all observations including multiple observations
from the same subject.
Event Type Placebo Tamoxifen Total
Type I: Local or regional recurrence 73 40 113
Type II: Second primary in contralateral breast 32 32 64
Type III: Distant recurrence, other second primary or death 204 184 388
No events 127 148 275
Table 6.1 gives the number of events by treatment group for all observations, including
multiple observations from the same subject. The most common event type was a Type
III event. Subjects receiving placebo had more events for all event types, except for Type
II events where both groups had exactly the same number of events. The original B-14
manuscript (Fisher et al., 1989, 1996) reported that there was a significant reduction of new
primary cancers in the contralateral breast for all women receiving tamoxifen in the B-14
study. From the counts in Table 6.1 for Type II events it is clear that this analysis will not
reach the same conclusion. This difference is most likely because this analysis used a subset
of the original data and has less power to detect a difference between treatment groups.
Among the 95 subjects who had multiple events about 57% experienced both a Type I and
a Type III event and about 20% had a Type II event and a Type III event.
It is reasonable to assume that multiple event times for the same patient are correlated
and that the occurrence of any one event type can affect the probability of the other event
times. Thus the assumptions of the proportional hazards model are violated and this model
is not appropriate. This sections fits the cause-specific hazard frailty model to the B-14
data adjusting for age and treatment assuming both a univariate and trivariate normal
distribution for the random effects. This will allow estimation of the treatment effect for
different types of events while accounting for their correlations and competing risks.
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Table 6.2: Estimates of the cause-specific hazard frailty model univariate case; and esti-
mates from fitting the cause-specific hazard model for each event type ignoring the effect of
clustering.
With Random Effects Without Random Effects
Event Type Effect Estimate 95% CI Estimate 95% CI
Type I Age -0.015 (-0.036, 0.005) -0.016 (-0.034, 0.002)
Treatment -0.742 (-1.186, -0.299) -0.628 (-1.014, -0.243)
Type II Age 0.002 (-0.028, 0.025) -0.001 (-0.025, 0.024)
Treatment -0.179 (-0.716, 0.357) -0.041 (-0.532, 0.449)
Type III Age 0.016 (0.001, 0.031) 0.017 (0.007, 0.027)
Treatment -0.262 (-0.556, 0.032) -0.136 (-0.336, 0.063)
Random Effect Variance 1.895 p-value = 0.019
CI stands for confidence interval.
The regression coefficients and estimated variance of the random effects assuming a
univariate normal distribution with just one random effect per subject are given in Table
6.2. These estimates as well as the corresponding relative risks refer to comparisons within
a cluster that share the same frailty. In this case clusters correspond to individual subjects.
Therefore adjusting for age, the relative risk of a Type I event for an individual on tamoxifen
compared to the same individual being on placebo is 0.48 with a 95% confidence interval
(CI) of (0.31, 0.74). For the other event types after adjusting for age, subjects receiving
tamoxifen did not have a statistically significant lower risk of experiencing the respective
event type then had that same subject received placebo. A subject’s age had no significant
effect on any outcome. Since this is a cause-specific hazard frailty model, the estimated
effects for any event type in Table 6.2 represent the pure effect of the covariate, for one type
of event when the other types do not exist (Prentice et al., 1978).
The predicted cumulative incidence (Cheng et al., 1998) curves of a Type I event for a
55 years old women are given in Figure 6.1. The incidence of a Type I event increases much
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Figure 6.1: Predicted cumulative incidence of Type I events, for an average subject when
V = 0 a high risk subject when V = 0.82 (75th percentile) and a low risk subject when
V = −1.07 (25th percentile).
faster for the placebo group compared to the tamoxifen group. Ten years after surgery an
average women on tamoxifen has a 7% chance of a local or regional recurrence while a women
on placebo has a 13% chance. This probability increases for women who are at higher risk
and decreases for women who are at low risk. The the probability of a Type I event for a
high risk subject on Tamoxifen is 12% while the probability for that same women on placebo
is 21%. Similarly, a low risk subject on Tamoxifen has a 3% chance and a 5% chance of a
Type I event if they were on placebo.
The random effects are assumed to be normally distributed. In this case the predicted
random effects are skewed right (Figure 6.2), with approximately half of the predicted effects
being less than 0. The estimated 25th and 75th percentiles are respectively -1.07 and 0.82.
Effects less than 0 correspond to individuals who are less frail than an average person from
the study population; an average person has no effect V = 0. In Figure 6.2, the predicted
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Figure 6.2: Predicted frailty versus the first observed event time for each subject; boxplot
on the right hand side is the distribution of the predicted random effects.
random effects are large for subjects who had an event early and decrease for later event
times. Thus those subjects who had an event early are more frail than those who survived
longer (section 3.1.2). The predicted random effects for every subject who did not have an
event is less than 0, this is reasonable since there is no evidence from the observed data that
these subjects should be at higher risk than an average person from the study population.
The estimated variance of the random effects is 1.895 (p-value = 0.019), this suggests
a fairly heterogeneous group of subjects. Moreover, the clustering effect is significant and
should be considered in this analysis. Ignoring the correlation between event times and
fitting the cause-specific hazard model for each event time without random effects results
in much lower estimates of the treatment effect (Table 6.2). Moreover, the model with one
random effect per cluster has an AIC = 6967.8, while the model with no random effects
has an AIC = 6970.1. Further indicating that ignoring the correlation between event times
results in a poorer fit of the data.
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Table 6.3: Estimates of the cause-specific hazard frailty model trivariate case.
Event Type Effect Estimate Standard Error 95% CI
Type I Age -0.017 0.010 (-0.036, 0.002)
Treatment -0.684 0.211 (-1.097, -0.271)
Type II Age 0.002 0.013 (-0.027, 0.024)
Treatment -0.111 0.260 (-0.621, 0.399)
Type III Age 0.016 0.006 (0.004, 0.028)
Treatment -0.203 0.125 (-0.448, 0.042)
Type I Variance 0.789
Type II Variance 0.706
Type III Variance 0.771
Type I, Type II Correlation 0.886
Type I, Type III Correlation 0.848
Type II, Type III Correlation 0.897
CI stands for confidence interval.
Additionally, the cause-specific hazard frailty model was fit assuming a trivariate normal
distribution with one random effect per event type (three random effects per subject); an
exchangeable correlation structure was used. This model is more general allowing negative
correlation between event types, but is also more complex. Several different starting values
were used to allow for the possibility of a negative association between random effects.
The estimated regression coefficients along with standard errors and confidence intervals
as well as estimated variance components are given in Table 6.3. The estimated treatment
effects for each event type are less than the corresponding estimates for the univariate case
in Table 6.2. Subjects on tamoxifen had a significantly lower risk of a Type I event compared
to subjects on placebo; tamoxifen did not significantly lower the risk for other event types.
The estimated variance of the random effects for each event type are all similar ranging from
0.706 to 0.789. There is also a strong positive correlation between the random effects for
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each event type, indicating that subjects who have a local or regional recurrence will also be
at greater risk for a second primary cancer in the contralateral breast as well as any of the
Type III events. The greater risk is because subjects who have a large random effect for a
Type I event will also tend to have a large random effect for a Type II and Type III event,
and larger random effects increases the risk of failure for an individual or cluster.
For this model the AIC = 6980.2, which is larger than the AIC for the univariate case
AIC = 6967.8 and for the proportional hazards model AIC = 6970.1. Indicating that the
data do not fit this model well. One possible explanation for the poor model fit is the lack
of repeated observations only 95 subjects had repeated events. This model may require a
larger dataset with more observations per cluster.
6.2 COMPETING RISKS WITHIN CENTERS
The purpose of this section will be to analyze the B-14 data to determine the effect of
treatment on local or regional recurrence while accounting for variation between centers in
the presence of competing risks. There were 167 centers in the B-14 trial. The number of
subjects at each center ranged from 1 to 241, with the average center having 17 subjects and
half of the centers having 8 or fewer subjects.
The analysis in this section uses all of the randomized B-14 patients; 2817 eligible patients
with follow-up where 1413 were treated with tamoxifen and 1404 received placebo. The
Table 6.4: First observed event type by treatment group
Event Type Placebo Tamoxifen Total
Type I: Local or regional recurrence 205 109 314
Type II: Distant recurrence, second primary or death 671 632 1303
No events 537 663 1200
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Table 6.5: Estimates of the subhazard frailty model.
Event Type Effect Estimate Standard Error 95% CI
Type I Age -0.026 0.005 (-0.037, 0.015)
Tumor Size 0.081 0.043 (-0.003, 0.164)
Treatment -0.674 0.119 (-0.907, -0.441)
Center Effect Variance 0.058 p-value = 1
CI stands for confidence interval.
average age of a subject was 55 and the average tumor size was about 2 centimeters. For
this analysis, there will be two event types. The first type is, local or regional recurrence
(Type I) and the second type is a new primary cancer, distant recurrence or death (Type
II). Only the event that occurs first is of interest in this analysis, repeated event times are
not considered. Table 6.4 gives the number of first observed event types by treatment group.
Patients receiving tamoxifen experienced fewer Type I and Type II events compared to those
on placebo.
The subhazard frailty model fitted the time to Type I events adjusting for age, treatment
group and tumor size while accounting for the variation between centers. The results are
shown in Table 6.5; recall that these effects have a center-specific interpretation. Based
on this analysis, tamoxifen significantly reduced the risk of a local or regional recurrence.
Women on tamoxifen had about half the risk of a Type I event compared to a women on
placebo from the same center; relative risk is 0.51 with a 95% CI of (0.40, 0.64). Neither age
nor tumor size were significantly associated with a Type I event.
There is no significant variation between centers, p-value=1. This lack of variation is
expected in a well-designed clinical trial. In fact, the Fine and Gray (1999) model gives a
better fit AIC = 4855.0 compared to the subhazard frailty model AIC = 4871.5. Since
there was no significant center effect the estimates in Table 6.5 are very similar to the results
returned by the Fine and Gray (1999) model (results now shown).
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Figure 6.3: Histogram of predicted random effects with a normal density curve
Predicted random effects were very similar ranging from -0.16 to 0.3, the average was 0.04,
the 25th percentile was -0.03 and the 75th percentile was 0.10. Figure 6.3 gives a histogram
of the predicted frailties with an imposed normal density. The frailties are roughly symmetric
with a large number of random effects just under zero.
The predicted cumulative incidence (Fine and Gray, 1999) for both treatment types
is given in Figure 6.4. An average women who is 55 years old and has a tumor size of 2
centimeters has a 5% chance of a Type I event within 10 years of surgery while someone from
the same center on placebo had an 9% chance. Given the little variation between centers
the predicted cumulative incidence for women from a high risk center and low risk center
are close to the average center.
Figure 6.5 plots the predicted cumulative incidence for an average subject of age 55 with
a tumor size of 2 centimeters 20 years after surgery versus the predicted random effect for
that subject’s center. The solid line depicts the predicted cumulative incidence from the
subhazard frailty model and the circles correspond to the observed cumulative incidences at
20 years for the cluster whose predicted random effect is given on the x-axis. The size of the
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circles are proportional to the size of the center. The predicted cumulative incidence for an
average women relates fairly well to the observed cumulative incidence. Centers with larger
samples are close to the predicted value, while small centers with no cases are not.
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Figure 6.4: Predicted Type I cumulative incidence for subjects from: an average center V =0,
high risk center V = 0.10 (75th percentile), and low risk center V = −0.03 (25th percentile)
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Figure 6.5: Predicted cumulative incidence versus predicted random effect.
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7.0 DISCUSSION
Frailty models, an extension of the proportional hazards models, are used to model the
association between clustered event times or adjust for unobserved heterogeneity by including
a latent random effect that acts multiplicatively on the baseline hazard function. When
competing risks are present within clusters either the cause-specific hazard frailty model or
the subhazard frailty model can be used to explain the relationship between covariates and
a time to event outcome.
H-likelihood provides a new estimation procedure for fitting these types of models that is
computationally efficient and readily produces estimated standard errors of the parameters
compared to using the EM algorithm. Furthermore, when there is little information due to
high censoring and/or a rare event type, the h-likelihood will provide less biased estimates
for the subhazard model compared to the PPL method; especially for the frailty parameter.
Simulation results demonstrate that the h-likelihood performs well for all of the competing
risks frailty models giving reasonable estimates for small cluster sizes.
A drawback of using the h-likelihood is that it can be difficult to implement because of
the numerous derivatives that need to be calculated. Once the derivatives are calculated,
though, the analysis is computationally efficient. Whereas the EM algorithm will always be
computationally intensive. Moreover, the h-likelihood procedure presented here is mainly
focused on estimating regression coefficients while accounting for the correlation between
event types. This is particularly meaningful in clinical trials when the objective is to assess
the effect of treatment. In other studies the correlation between event types may be more
important. When a multivariate distribution is assumed it is possible to estimate the corre-
lation between the random effects using the h-likelihood. However, there are other methods
such as Bandeen-Roche and Liang (2002), Cheng et al. (2009) that maybe more appropriate
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when the main objective of the analysis is the association between competing risks and not
the effect of risk factors, in the presence of competing risks.
This work only considered lognormal frailty distributions. However it may be very in-
teresting to consider other distributions when competing risks are present. In particular
the compound Poisson frailty distribution. This distribution is unique in that it allows for
a subgroup of zero frailty, a subgroup where no one experiences the event. While this is
actually not feasible it may be a reasonable distribution when a large portion of the sample
did not experience the event of interest. Consider Figure 6.2, with this example there were
several people with a small predicted frailty because they did not have any events. So it
would be reasonable to consider this a subgroup of people who do not experience any events.
An advantage of the compound Poisson distribution is that it has a closed form Laplace
transform which means that it will be simpler to calculate the marginal survival function.
Another area of future work is extending the subhazard frailty model to allow for bivariate
distributed frailties. This would make the subhazard frailty model as general and flexible as
the cause-specific hazard model. It would also be interesting to consider modeling individual
unobserved heterogeneity in the subhazard model. Simulation results from Ha et al. (2010)
show a dramatic improvement in reducing the bias of estimates in the univariate frailty
model using hierarchical likelihood compared to using the marginal likelihood or penalized
partial likelihood. Thus it would be worthwhile to see how the Ha et al. (2010) method
applies to the subhazard frailty model.
This additional work will hopefully extend the uses of h-likelihood and provide better
tools for analyzing competing risks data.
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APPENDIX
R PROGRAM FOR H-LIKELIHOOD ESTIMATION
Description
Perform hierarchical likelihood estimation of the shared frailty model, cause-specific frailty
model and subhazard frailty model. Assuming either a univariate normal or multivariate
normal distribution for the random effects V , where different covariance structures can be
assumed for the multivariate normal distribution.
Usage
hlike.frailty(formula, data, inits, order=1, frailty.cov="none",
subHazard=FALSE, alpha=.05, MAX.ITER=100, TOL=1E-6)
Arguments
formula formula, left-hand side of ∼ is a CmpRsk object (see details), right-hand
side is predictors (currently limited to numeric main effects), must
include a cluster term that identifies the cluster variable.
data dataframe containing the variables used in the formula
inits list of initial values, three named components: beta, v and theta
order numeric, order of the Laplace approximation, 0=no order, 1=first-order,
2=second-order; second-order only applies to models with a univariate
normal distribution
frailty.cov character string "none", "independent", "exchangeable" or
"unstructured" specifying the covariance structure for a multivariate
normal distribution; "none" indicates univariate normal distribution
subHazard logical, if TRUE fits the subhazard frailty model
alpha numeric, 100(1-alpha)% confidence intervals
MAX.ITER numeric, maximum number of iterations
TOL numeric, tolerance limit
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Details
A CmpRsk object is used as the response variable in the model formula. It is created using
the function CmpRsk(time, index), where time is the event time and index is an event in-
dicator; values of index must be sequential whole numbers where 0 denotes right censoring
and positive numbers refer to different event types.
If subHazard=TRUE then the subhazard frailty model is fit where the event of interest is
when index=1.
Convergence is determined by,
max
{∣∣∣βˆ(i+1) − βˆ(i)∣∣∣ , ∣∣∣θˆ(i+1) − θˆ(i)∣∣∣} < TOL
Value
Returns a list with class hlike containing the following components:
beta Estimated regression coefficients along with standard errors and
confidence intervals
theta Estimated variance components
v Predicted random effects
theta.pvalue P-value for testing H0 : θ = 0, only for univariate normal models
lambda.0 List (one component per event type) of predicted baseline hazard
rate for each event time evaluated at returned estimates
time List (one component per event type) of unique event times
for each event type
hp Profile h-likelihood evaluated at returned estimates
Ahp Adjusted profile h-likelihood evaluated at returned estimates
loglik.noFrailty Maximum log-likelihood for corresponding competing risks model
with no frailties
AIC Akaike’s Information Criterion (AIC)
converge Indicate convergence, 1=converge and 0=reached MAX.ITER
iterations Number of iterations
call Function call
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Examples
# The kidney dataset is part of the survival library. It is not a competing
# risks dataset but can still serve as an example for using hlike.frailty
n = length(unique(kidney$id))
theta.init = 0.5
v.init = qnorm(runif(n, min=pnorm(-2, sd=sqrt(theta.init)),
max=pnorm(2, sd=sqrt(theta.init))), sd=sqrt(theta.init))
beta.init = coxph(Surv(time, status)~age+sex, data=kidney)$coef
# Shared Frailty
hlike.frailty(CmpRsk(time, status)~age+sex+cluster(id), data=kidney,
inits=list(beta=beta.init, theta=theta.init, v=v.init),
order=1, frailty.cov="none", MAX.ITER=300)
# Subhazard Frailty
hlike.frailty(CmpRsk(time, status2)~age+sex+cluster(id), data=kidney,
inits=list(beta=beta.init, theta=theta.init, v=v.init),
order=1, frailty.cov="none", subHazard=TRUE, MAX.ITER=300)
# Cause-Specific Hazard Frailty (treat censoring as a second event type)
kidney$status2=kidney$status+1
# Univariate case
beta.init <- c(sapply(1:2, function(k)
coxph(Surv(time, status2==k)~age+sex, data=kidney)$coef))
hlike.frailty(CmpRsk(time, status2)~age+sex+cluster(id), data=kidney,
inits=list(beta=beta.init, theta=theta.init, v=v.init),
order=1, frailty.cov="none", MAX.ITER=100)
# Bivariate case - exchangeable
theta.init <- matrix(c(1,.5,.5,1),nrow=2)
v.init <- MASS::mvrnorm(n, mu=rep(0, 2), Sigma=theta.init)
hlike.frailty(CmpRsk(time, status2)~age+sex+cluster(id), data=kidney,
inits=list(beta=beta.init, theta=theta.init, v=v.init),
order=1, frailty.cov="exchangeable", MAX.ITER=100)
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# hlike.frailty.R
# -------------------------------------------------------------------------------
library(survival)
library(cmprsk)
library(Matrix)
# Simple functions to assist hlike.frailty()
# -------------------------------------------------------------------------------
# Calculate the trace of a matrix
trace <- function(x) {stopifnot(is.matrix(x), nrow(x)==ncol(x)); sum(diag(x))}
# Create a block diagonal matrix
block <- function(...) {as.matrix(bdiag(...))}
# Binary operator return x without y
"%w/o%" <- function(x, y) {!x %in% y}
# Pairwise sum of multiple objects (vectors or matrices)
p.sum <- function(...) {
x <-list(...)
eval(parse(text=paste("x[[", 1:length(x), "]]", sep="", collapse="+")))
}
# Create an S3 class "CmpRsk"
CmpRsk <- function(time, index) {
# Verify Arugments
if(any(time<0)) stop("Invalid time")
if(any(index<0, diff(sort(unique(index)))!=1)) stop("Invalid index")
# Create object
temp <- cbind(time, index)
class(temp) = "CmpRsk"
return(temp)
}
# Basic print and summary methods for a "hlike" object
print.hlike <- summary.hlike <- function(object) {
print(object$beta); cat("\n"); print(object$theta);
cat("\n",ifelse(object$converge==1, "Successfully Converged",
"Failed to Converge"),"\n")
}
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hlike.frailty <- function(formula, data, inits, order=1, frailty.cov="none",
subHazard=FALSE, alpha=.05, MAX.ITER=100, TOL=1E-6) {
# Create a sorted data matrix from the given formula and dataset.
# -----------------------------------------------------------------------------
mf <- model.frame(formula, data)
if(!is(model.response(mf), "CmpRsk") | is.na(pmatch("cluster", names(mf))))
stop("Invalid formula")
resp <- pmatch("CmpRsk", names(mf))
clust <- pmatch("cluster", names(mf))
pred <- names(mf)[setdiff(1:ncol(mf), c(resp, clust))]
temp.data <- data.frame(unclass(mf[,resp]), mf[,pred], mf[,clust])
names(temp.data) <- c("time", "index", pred, "cluster")
sort.data <- temp.data[order(temp.data$time),]
N <- nrow(sort.data) # Total sample size
n <- length(unique(sort.data$cluster)) # Number of clusters
m <- max(sort.data$index) # Number of event types
p <- length(pred) # Number of predictors
# Create design matrices for fixed covariates and the frailty term
X <- as.matrix(sort.data[,pred]); colnames(X)=pred
Z <- model.matrix(~ 0 + factor(sort.data$cluster)); colnames(Z)=NULL
# Number of frailty parameters and derivative of the covariance matrix (dSigma)
# -----------------------------------------------------------------------------
if(m==1 & frailty.cov!="none") stop("Invalid frailty.cov argument")
if(subHazard & frailty.cov!="none") stop("Invalid frailty.cov argument")
s <- switch(frailty.cov,
none = 1,
independent = m,
exchangeable = m+1,
unstructured = sum(1:m),
stop("Invalid frailty.cov argument"))
dSigma <- function(q) {
dSigma <- matrix(0, nrow=min(m,s), ncol=min(m,s))
zero=rep(0,s); zero[q] <- 1
if(frailty.cov=="independent") { dSigma = diag(zero)
} else if(frailty.cov=="exchangeable") {
if(q<=nrow(dSigma)) dSigma <- diag(zero[-s])
if(q>nrow(dSigma)) dSigma[lower.tri(dSigma) | upper.tri(dSigma)]=1
} else if(frailty.cov=="unstructured") {
dSigma[lower.tri(dSigma, diag=TRUE)] <- zero
dSigma[upper.tri(dSigma)] <- dSigma[lower.tri(dSigma)]
} else if(frailty.cov=="none") dSigma = 1
return(dSigma)
}
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# If the subhazard model is being fitted (subHazard==TRUE) then the event of
# interest is event 1. The function G is the Kaplan-Meier estimate of the
# survival function for the censoring distribution.
# -----------------------------------------------------------------------------
if(subHazard) {
m = 1
fit.censor <- survfit(Surv(sort.data$time, sort.data$index==0)~1)
G <- function(t) {
# The times argument of summary.survfit requires that t be sorted.
# After getting survival times at each t, reorder s to match the
# original order of t. Return a vector of 1s if there is no censoring.
s <- summary(fit.censor, times=sort(t))$surv
if(any(sort.data$index==0)) { return(s[match(t, sort(t))])
} else return(rep(1, length(t)))
}
}
# Unique event times (y), number of events per unique time (d), event indicator
# (delta) and risk matrix (atRisk) for event type k, k=1,...,m
#
# The atRisk matrix is a matrix of the risk set. Columns are unique event times
# with one row for each observation. A 1 denotes that the subject is still at
# risk; with sorted data resembles a lower-triangular matrix.
# -----------------------------------------------------------------------------
# Calculate, y, d, delta, and atRisk for each event type
prepData <- function(event) {
y <- unique(with(sort.data, time[index==event]))
d <- with(sort.data,tapply(index[index==event],time[index==event],length))
num.y <- length(y)
delta <- ifelse(sort.data$index==event,1,0)
atRisk <- matrix(0, nrow=N, ncol=num.y)
for(j in 1:num.y) {
if(subHazard) {
id <- which(sort.data$time>=y[j]|sort.data$index %w/o% c(0,event))
atRisk[id, j] <- G(y[j])/G(pmin(y[j], sort.data$time[id]))
} else {
id <- which(sort.data$time >= y[j])
atRisk[id, j] <- 1
}
}
return(list(y=y, d=d, delta=delta, atRisk=atRisk))
}
atRisk <- lapply(1:m, function(x) prepData(x)$atRisk)
delta <- lapply(1:m, function(x) prepData(x)$delta)
y <- lapply(1:m, function(x) prepData(x)$y)
d <- lapply(1:m, function(x) prepData(x)$d)
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# Variables for saving the iteration history of the parameters
beta <- array(dim=c(p,m,MAX.ITER+1),dimnames=list(colnames(X),Type=1:m,NULL))
theta <- array(dim=c(min(m,s), min(m,s), MAX.ITER+1))
v <- array(dim=c(n, min(m,s), MAX.ITER+1),
dimnames=list(Group=1:n, Type=1:min(m,s), NULL))
# Initial values
if(!all(c("beta","theta","v")%in%names(inits))) stop("Invalid initial values")
if(min(m,s)!=ncol(as.matrix(inits$v))) stop("Invalid initial values")
beta[,,1] <- inits$beta
theta[,,1] <- inits$theta
v[,,1] <- inits$v
# Newton-Raphson Method
# -----------------------------------------------------------------------------
exp.eta <- lambda.0 <- Lambda.0 <- list()
diag.exp.eta <- diag.Lambda.0 <- lambda.0.sq <- list()
dexp.eta <- dlambda.0 <- dLambda.0 <- list()
ddiag.exp.eta <- ddiag.Lambda.0 <- dlambda.0.sq <- list()
d2exp.eta <- d2lambda.0 <- d2Lambda.0 <- list()
d2diag.exp.eta <- d2diag.Lambda.0 <- d2lambda.0.sq <- list()
ddiag.exp.eta<-ddiag.Lambda.0<-dlambda.0<-dlambda.0.sq<-replicate(s,list())
W <- replicate(m, list())
dW <- replicate(s, list())
d2W <- replicate(sum(1:s), list())
q.index = cbind(rep(1:s, times=s:1), unlist(sapply(1:s, function(q) q:s)))
colnames(q.index) = c("q1", "q2")
for(i in 1:MAX.ITER) {
SigmaInv = solve(theta[,,i])
SigmaInv.dSigma.SigmaInv = lapply(1:s, function(q)
solve(theta[,,i])%*%dSigma(q)%*%solve(theta[,,i]))
Q <- kronecker(SigmaInv, diag(n))
Q.prime<-lapply(SigmaInv.dSigma.SigmaInv,function(x) kronecker(-x,diag(n)))
Q.prime2 <- mapply(q1=q.index[,"q1"], q2=q.index[,"q2"], function(q1, q2)
kronecker(SigmaInv.dSigma.SigmaInv[[q2]]%*%dSigma(q1)%*%SigmaInv +
SigmaInv%*%dSigma(q1)%*%SigmaInv.dSigma.SigmaInv[[q2]],diag(n)),
SIMPLIFY=FALSE)
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for(k in 1:m) {
exp.eta[[k]] <- as.vector(exp(X%*%beta[,k,i] + Z%*%v[,min(k,s),i]))
lambda.0[[k]] <- as.vector(d[[k]])/as.vector(t(atRisk[[k]])%*%
exp.eta[[k]])
Lambda.0[[k]] <- as.vector(atRisk[[k]]%*%diag(lambda.0[[k]])%*%
rep(1, ncol(atRisk[[k]])))
diag.exp.eta[[k]] <- diag(exp.eta[[k]])
diag.Lambda.0[[k]] <- diag(Lambda.0[[k]])
lambda.0.sq[[k]] <- diag(lambda.0[[k]]^2/d[[k]])
W[[k]] <- diag.exp.eta[[k]]%*%diag.Lambda.0[[k]] -
diag.exp.eta[[k]]%*%atRisk[[k]]%*%lambda.0.sq[[k]]%*%
t(atRisk[[k]])%*%diag.exp.eta[[k]]
}
# Gradient of profile h-like with respect to beta and v condtional on theta
# --------------------------------------------------------------------------
dhp.dbeta <- unlist(lapply(1:m, function(k) t(X)%*%
(delta[[k]]-diag.exp.eta[[k]]%*%Lambda.0[[k]])))
dhp.dv <- do.call(ifelse(frailty.cov=="none", "p.sum", "c"),
lapply(1:m, function(k) t(Z)%*%(delta[[k]]-
diag.exp.eta[[k]]%*%Lambda.0[[k]])))
G <- c(dhp.dbeta, dhp.dv + kronecker(-SigmaInv,diag(n))%*%as.vector(v[,,i]))
# Hessian of profile h-like with respect to beta and v condtional on theta
# --------------------------------------------------------------------------
H.XX <- block(lapply(W, function(w) t(X)%*%w%*%X))
H.XZ <- do.call(ifelse(frailty.cov=="none", "rbind", "block"),
lapply(W, function(w) t(X)%*%w%*%Z))
H.ZX <- do.call(ifelse(frailty.cov=="none", "cbind", "block"),
lapply(W, function(w) t(Z)%*%w%*%X))
H.ZZ <- do.call(ifelse(frailty.cov=="none", "p.sum", "block"),
lapply(W, function(w) t(Z)%*%w%*%Z))
H <- rbind(cbind(H.XX, H.XZ),
cbind(H.ZX, H.ZZ + Q))
H.inv <- solve(H)
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# Update estimates of beta and v
# -------------------------------------------------------------------------
est <- c(beta[,,i], v[,,i]) + H.inv%*%G
beta[,,i+1] <- est[1:(m*p),1]
v[,,i+1] <- est[-(1:(m*p)),1]
# Gradient of the adjusted profile h-like with respect to theta given
# beta and v
# -------------------------------------------------------------------------
dv.dtheta <- lapply(1:s,function(q)
matrix(-solve(H.ZZ+Q)%*%Q.prime[[q]]%*%as.vector(v[,,i]),ncol=min(m,s)))
if(order>0)
for(q in 1:s) {
for(k in 1:m) {
dexp.eta[[k]] <- as.vector(exp.eta[[k]]*
(Z%*%dv.dtheta[[q]][,min(k,s)]))
dlambda.0[[q]][[k]] <- -(d[[k]]/as.vector((t(atRisk[[k]])%*%
exp.eta[[k]])^2))*as.vector(t(atRisk[[k]])%*%dexp.eta[[k]])
dLambda.0[[k]] <- as.vector(atRisk[[k]]%*%
diag(as.vector(dlambda.0[[q]][[k]]))%*%rep(1,ncol(atRisk[[k]])))
ddiag.exp.eta[[q]][[k]] <- diag(dexp.eta[[k]])
ddiag.Lambda.0[[q]][[k]] <- diag(dLambda.0[[k]])
dlambda.0.sq[[q]][[k]] <- diag(2*lambda.0[[k]]*
dlambda.0[[q]][[k]]/d[[k]])
diag.exp.eta.atRisk = diag.exp.eta[[k]]%*%atRisk[[k]]
dW[[q]][[k]] <- (ddiag.exp.eta[[q]][[k]]*diag.Lambda.0[[k]])+
(diag.exp.eta[[k]]*ddiag.Lambda.0[[q]][[k]])-
(ddiag.exp.eta[[q]][[k]]%*%atRisk[[k]]%*%lambda.0.sq[[k]]%*%
t(diag.exp.eta.atRisk))-
(diag.exp.eta.atRisk%*%dlambda.0.sq[[q]][[k]]%*%
t(diag.exp.eta.atRisk)) -
(diag.exp.eta.atRisk%*%lambda.0.sq[[k]]%*%
t(ddiag.exp.eta[[q]][[k]]%*%atRisk[[k]]))
}
}
if(order==0) dW<-replicate(s,list(replicate(m,list(matrix(0,nrow=N,ncol=N)))))
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dH.XX <- lapply(dW,function(dW) block(lapply(dW,function(w) t(X)%*%w%*%X)))
dH.XZ <- lapply(dW, function(dW)
do.call(ifelse(frailty.cov=="none", "rbind", "block"),
lapply(dW, function(w) t(X)%*%w%*%Z)))
dH.ZX <- lapply(dW, function(dW)
do.call(ifelse(frailty.cov=="none", "cbind", "block"),
lapply(dW, function(w) t(Z)%*%w%*%X)))
dH.ZZ <- lapply(dW, function(dW)
do.call(ifelse(frailty.cov=="none", "p.sum", "block"),
lapply(dW, function(w) t(Z)%*%w%*%Z)))
dH.dtheta <- lapply(1:s, function(q)
rbind(cbind(dH.XX[[q]], dH.XZ[[q]]),
cbind(dH.ZX[[q]], dH.ZZ[[q]] + Q.prime[[q]])))
G.theta <- sapply(1:s, function(q)
sum(apply(as.matrix(v[,,i]), 1, function(v) -
.5*trace(SigmaInv%*%dSigma(q))+
.5*t(v)%*%SigmaInv.dSigma.SigmaInv[[q]]%*%v))-
.5*trace(H.inv%*%dH.dtheta[[q]]))
# Hessian of the adjusted profile h-like with respect to theta given
# beta and v
# --------------------------------------------------------------------
dv2.dtheta2 <- lapply(1:sum(1:s), function(q) {
q1 = q.index[q,"q1"]
q2 = q.index[q,"q2"]
matrix(-solve(H.ZZ+Q)%*%((dH.ZZ[[q1]] + Q.prime[[q1]])%*%
as.vector(dv.dtheta[[q2]]) + Q.prime[[q2]]%*%
as.vector(dv.dtheta[[q1]])+Q.prime2[[q]]%*%
as.vector(v[,,i])), ncol=min(m,s))
})
if(order>0)
for(q in 1:sum(1:s)) {
q1=q.index[q,"q1"]
q2=q.index[q,"q2"]
for(k in 1:m) {
d2exp.eta[[k]] <- as.vector((Z%*%dv.dtheta[[q1]][,min(k,s)])*
(Z%*%dv.dtheta[[q2]][,min(k,s)])*
exp.eta[[k]]+(Z%*%dv2.dtheta2[[q]][,min(k,s)])*exp.eta[[k]])
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d2lambda.0[[k]] <- as.vector(-(lambda.0.sq[[k]]%*%t(atRisk[[k]])%*%
ddiag.exp.eta[[q2]][[k]]%*%
Z%*%dv.dtheta[[q1]][,min(k,s)] +
lambda.0.sq[[k]]%*%t(atRisk[[k]])%*%diag.exp.eta[[k]]%*%
Z%*%dv2.dtheta2[[q]][,min(k,s)] +
dlambda.0.sq[[q2]][[k]]%*%t(atRisk[[k]])%*%diag.exp.eta[[k]]%*%
Z%*%dv.dtheta[[q1]][,min(k,s)]))
d2Lambda.0[[k]] <- as.vector(atRisk[[k]]%*%
diag(as.vector(d2lambda.0[[k]]))%*%rep(1, ncol(atRisk[[k]])))
d2diag.exp.eta[[k]] <- diag(d2exp.eta[[k]])
d2diag.Lambda.0[[k]] <- diag(d2Lambda.0[[k]])
d2lambda.0.sq[[k]] <- diag((2*lambda.0[[k]]*dlambda.0[[q1]][[k]]*
dlambda.0[[q2]][[k]] + 2*lambda.0[[k]]*d2lambda.0[[k]])/d[[k]])
diag.exp.eta.atRisk = diag.exp.eta[[k]]%*%atRisk[[k]]
ddiag.exp.eta.q1.atRisk = ddiag.exp.eta[[q1]][[k]]%*%atRisk[[k]]
ddiag.exp.eta.q2.atRisk = ddiag.exp.eta[[q2]][[k]]%*%atRisk[[k]]
aa = d2diag.exp.eta[[k]]*diag.Lambda.0[[k]] +
(ddiag.exp.eta[[q1]][[k]]*ddiag.Lambda.0[[q2]][[k]] +
ddiag.exp.eta[[q2]][[k]]*ddiag.Lambda.0[[q1]][[k]]) +
diag.exp.eta[[k]]*d2diag.Lambda.0[[k]]
bb = (d2diag.exp.eta[[k]]%*%atRisk[[k]]%*%lambda.0.sq[[k]]%*%
t(diag.exp.eta.atRisk)) +
(ddiag.exp.eta.q1.atRisk%*%dlambda.0.sq[[q2]][[k]]%*%
t(diag.exp.eta.atRisk)) +
(ddiag.exp.eta.q1.atRisk%*%lambda.0.sq[[k]]%*%
t(ddiag.exp.eta.q2.atRisk))
cc = (ddiag.exp.eta.q2.atRisk%*%dlambda.0.sq[[q1]][[k]]%*%
t(diag.exp.eta.atRisk)) +
(diag.exp.eta.atRisk%*%d2lambda.0.sq[[k]]%*%
t(diag.exp.eta.atRisk)) +
(diag.exp.eta.atRisk%*%dlambda.0.sq[[q1]][[k]]%*%
t(ddiag.exp.eta.q2.atRisk))
dd = (ddiag.exp.eta.q2.atRisk%*%lambda.0.sq[[k]]%*%
t(ddiag.exp.eta.q1.atRisk)) +
(diag.exp.eta.atRisk%*%dlambda.0.sq[[q2]][[k]]%*%
t(ddiag.exp.eta.q1.atRisk)) +
(diag.exp.eta.atRisk%*%lambda.0.sq[[k]]%*%
t(d2diag.exp.eta[[k]]%*%atRisk[[k]]))
d2W[[q]][[k]] = aa-(bb+cc+dd)
}
}
if(order==0) d2W <- replicate(sum(1:s),
list(replicate(m, list(matrix(0, nrow=N, ncol=N)))))
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d2H.XX <- lapply(d2W, function(d2W)
block(lapply(d2W, function(w) t(X)%*%w%*%X)))
d2H.XZ <- lapply(d2W, function(d2W)
do.call(ifelse(frailty.cov=="none", "rbind", "block"),
lapply(d2W, function(w) t(X)%*%w%*%Z)))
d2H.ZX <- lapply(d2W, function(d2W)
do.call(ifelse(frailty.cov=="none", "cbind", "block"),
lapply(d2W, function(w) t(Z)%*%w%*%X)))
d2H.ZZ <- lapply(d2W, function(d2W)
do.call(ifelse(frailty.cov=="none", "p.sum", "block"),
lapply(d2W, function(w) t(Z)%*%w%*%Z)))
d2H.dtheta2 <- lapply(1:sum(1:s), function(q) {
rbind(cbind(d2H.XX[[q]], d2H.XZ[[q]]),
cbind(d2H.ZX[[q]], d2H.ZZ[[q]] + Q.prime2[[q]]))})
H.theta.temp <- sapply(1:sum(1:s), function(q)
{q1=q.index[q,"q1"]; q2=q.index[q,"q2"]
sum(apply(as.matrix(v[,,i]), 1, function(v) {
.5*trace(SigmaInv%*%dSigma(q2)%*%SigmaInv%*%dSigma(q1)) +
.5*t(v)%*%(SigmaInv%*%dSigma(q2)%*%SigmaInv.dSigma.SigmaInv[[q1]])%*%v +
.5*t(v)%*%(SigmaInv%*%dSigma(q1)%*%SigmaInv.dSigma.SigmaInv[[q2]])%*%v}))-
c(v[,,i])%*%Q.prime[[q1]]%*%c(dv.dtheta[[q2]]) +
.5*trace(-H.inv%*%dH.dtheta[[q1]]%*%H.inv%*%dH.dtheta[[q2]]+
H.inv%*%d2H.dtheta2[[q]])})
H.theta <- matrix(nrow=s, ncol=s)
H.theta[lower.tri(H.theta, diag=TRUE)] <- H.theta.temp
H.theta[upper.tri(H.theta)] <- H.theta[lower.tri(H.theta)]
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# Update estimates of theta
# -------------------------------------------------------------------------
if(order==2 & s!=1) stop("Invalid order argument")
if(order==0 | order==1) {
if(frailty.cov=="independent") {
theta[,,i+1] <- diag(as.vector(diag(theta[,,i]) +
solve(H.theta)%*%G.theta))
} else if(frailty.cov=="exchangeable") {
temp <- c(diag(theta[,,i]),unique(theta[,,i][lower.tri(theta[,,i])]))+
solve(H.theta)%*%G.theta
theta[,,i+1] <- diag(temp[1:(s-1)])
theta[,,i+1][lower.tri(theta[,,i+1])|upper.tri(theta[,,i+1])]<-temp[s]
} else if(frailty.cov=="unstructured") {
temp <- theta[,,i][lower.tri(theta[,,i], diag=TRUE)]+
solve(H.theta)%*%G.theta
theta[,,i+1][lower.tri(theta[,,i], diag=TRUE)] <- temp
theta[,,i+1][upper.tri(theta[,,i+1], diag=TRUE)] <-
theta[,,i+1][lower.tri(theta[,,i+1], diag=TRUE)]
} else if(frailty.cov=="none") {
theta[,,i+1] <- theta[,,i] + solve(H.theta)%*%G.theta
}
} else {
delta.i.plus <- lapply(delta, function(x)
tapply(x, sort.data$cluster, sum))
mu.i.plus <- lapply(1:m, function(k)
tapply(Lambda.0[[k]]*exp(X%*%beta[,k,i]), sort.data$cluster, sum))
dh.dv <- function(v, j) {
Reduce("+",delta.i.plus)[j]-exp(v)*
Reduce("+",mu.i.plus)[j]-v/theta[,,i]}
v.tilda <- sapply(1:n, function(x)
uniroot(dh.dv, c(-50,50), j=x, tol=1E-3)$root)
A <- exp(v.tilda)*Reduce("+", mu.i.plus)
trace.dS <-sum(6*A*theta[,,i]^(-2)*(A+1/theta[,,i])^(-3)-15*
A^2*theta[,,i]^(-2)*(A+1/theta[,,i])^(-4))
trace.d2S<-sum(12*A*theta[,,i]^(-3)*(A+1/theta[,,i])^(-3)-18*
A*theta[,,i]^(-4)*(A+1/theta[,,i])^(-4) -
30*A^2*theta[,,i]^(-3)*(A+1/theta[,,i])^(-4)+60*
A^2*theta[,,i]^(-4)*(A+1/theta[,,i])^(-5))
G.theta.order2 <- G.theta - trace.dS/24
H.theta.order2 <- H.theta - trace.d2S/24
theta[,,i+1] <- theta[,,i] + G.theta.order2/H.theta.order2
}
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# Convergence
# -------------------------------------------------------------------------
converge=0
if(max(abs(c(beta[,,i+1], theta[,,i+1])-
c(beta[,,i], theta[,,i])), na.rm=TRUE) < TOL){
converge=1
break
}
}
# Profile h-likelihood and Adjusted Profile h-likelihood
# -------------------------------------------------------------------------
h.p <- sum(sapply(1:m, function(k) sum(delta[[k]]*log(exp.eta[[k]])))) +
- sum(sapply(1:m, function(k)
sum(d[[k]]*log(as.vector(t(atRisk[[k]])%*%exp.eta[[k]]))))) +
sum(apply(as.matrix(v[,,i]), 1, function(v)
.5*log(det(SigmaInv/2/pi))-.5*t(v)%*%SigmaInv%*%v))
A.h.p <- h.p - .5*log(det(H))+(p+n)/2*log(2*pi)
AIC <- -2*A.h.p + 2*s # Akaike information criterion
# Confidence intervals and hypothesis tests
# -------------------------------------------------------------------------
# Estimates, standard errors, and CI for regression coefficients
beta.SE <- sqrt(diag(as.matrix(H.inv[1:(m*p), 1:(m*p)])))
lower.beta <- c(beta[,,i]) - qnorm(1-alpha/2)*beta.SE
upper.beta <- c(beta[,,i]) + qnorm(1-alpha/2)*beta.SE
beta.CI <- data.frame(rep(1:m,each=p), rep(colnames(X),times=m),
c(beta[,,i]), beta.SE, lower.beta, upper.beta)
colnames(beta.CI) <- c("Type", "Effect", "Estimate", "SE",
paste(alpha/2*100, "%", sep=""), paste((1-alpha/2)*100, "%", sep=""))
# Variance component estimates
Var.Comp <- paste("Sigma.", unlist(sapply(1:min(m,s),
function(q) q:min(m,s))), rep(1:min(m,s), times=min(m,s):1), sep="")
theta.Est <- data.frame(Var.Comp,
Estimate=theta[,,i][lower.tri(theta[,,i], diag=TRUE)])
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# Test H0: theta=0 for cause-specific and subHazard models when univariate
# normal distribution
if(subHazard==TRUE) {
loglik.noFrailty <- crr(sort.data$time, sort.data$index, X)$loglik
} else {
loglik.noFrailty <- sum(sapply(1:m,function(k)
coxph(Surv(time,index==k)~X,data=sort.data)$loglik[2]))
}
if(frailty.cov=="none") {
psi.hat <- -2*(loglik.noFrailty - A.h.p)
theta.pvalue <- ifelse(psi.hat<=0,1,0.5*pchisq(psi.hat,1,lower.tail=FALSE))
} else theta.pvalue=NULL
# Gather and output results
# -------------------------------------------------------------------------
v.out <- Z%*%v[,,i]; rownames(v.out)<-sort.data$cluster;
out <- list(beta=beta.CI, theta=theta.Est, v=v.out, theta.pvalue=theta.pvalue,
lambda.0=lapply(1:m, function(k) matrix(lambda.0[[k]],
dimnames=list(Time=y[[k]], Type=k))),
time=y, hp=h.p, Ahp=A.h.p, loglik.noFrailty=loglik.noFrailty, AIC=AIC,
converge=converge, iterations=i, call=match.call())
class(out) <- "hlike"
return(out)
}
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